<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur J Neurosci</journal-id><journal-id journal-id-type="publisher-id">ejn</journal-id><journal-title>The European Journal of Neuroscience</journal-title><issn pub-type="ppub">0953-816X</issn><issn pub-type="epub">1460-9568</issn><publisher><publisher-name>Blackwell Publishing Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1111/j.1460-9568.2009.06677.x</article-id><article-categories><subj-group subj-group-type="heading"><subject>Synaptic Mechanisms</subject></subj-group></article-categories><title-group><article-title>Induction and expression of GluA1 (GluR-A)-independent LTP in the hippocampus</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Romberg</surname><given-names>Carola</given-names></name><xref ref-type="aff" rid="au1">1</xref><xref ref-type="aff" rid="au2">2</xref></contrib><contrib contrib-type="author"><name><surname>Raffel</surname><given-names>Joel</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name><surname>Martin</surname><given-names>Lucy</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name><surname>Sprengel</surname><given-names>Rolf</given-names></name><xref ref-type="aff" rid="au3">3</xref></contrib><contrib contrib-type="author"><name><surname>Seeburg</surname><given-names>Peter H</given-names></name><xref ref-type="aff" rid="au3">3</xref></contrib><contrib contrib-type="author"><name><surname>Rawlins</surname><given-names>J Nicholas P</given-names></name><xref ref-type="aff" rid="au2">2</xref></contrib><contrib contrib-type="author"><name><surname>Bannerman</surname><given-names>David M</given-names></name><xref ref-type="aff" rid="au2">2</xref></contrib><contrib contrib-type="author"><name><surname>Paulsen</surname><given-names>Ole</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><aff id="au1"><label>1</label><institution>Department of Physiology, Anatomy and Genetics, University of Oxford</institution><addr-line>Oxford OX1 3PT, UK</addr-line></aff><aff id="au2"><label>2</label><institution>Department of Experimental Psychology, University of Oxford</institution><addr-line>Oxford, UK</addr-line></aff><aff id="au3"><label>3</label><institution>Max-Planck Institute of Medical Research, Department of Molecular Neurobiology</institution><addr-line>Heidelberg, Germany</addr-line></aff></contrib-group><author-notes><corresp id="cor1">Correspondence: Dr O. Paulsen, as above. E-mail: <email>ole.paulsen@dpag.ox.ac.uk</email></corresp></author-notes><pub-date pub-type="ppub"><month>3</month><year>2009</year></pub-date><volume>29</volume><issue>6</issue><fpage>1141</fpage><lpage>1152</lpage><history><date date-type="received"><day>11</day><month>9</month><year>2008</year></date><date date-type="rev-recd"><day>23</day><month>1</month><year>2009</year></date><date date-type="accepted"><day>26</day><month>1</month><year>2009</year></date></history><copyright-statement>Journal compilation &#x000a9; 2009 Federation of European Neuroscience Societies and Blackwell Publishing Ltd</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/"><p>Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.</p></license><abstract><p>Long-term potentiation (LTP) at hippocampal CA3&#x02013;CA1 synapses is thought to be mediated, at least in part, by an increase in the postsynaptic surface expression of &#x003b1;-amino-3-hydroxy-5-methyl-4-isoxazole proprionic acid (AMPA) receptors induced by <italic>N</italic>-methyl-<sc>d</sc>-aspartate (NMDA) receptor activation. While this process was originally attributed to the regulated synaptic insertion of GluA1 (GluR-A) subunit-containing AMPA receptors, recent evidence suggests that regulated synaptic trafficking of GluA2 subunits might also contribute to one or several phases of potentiation. However, it has so far been difficult to separate these two mechanisms experimentally. Here we used genetically modified mice lacking the GluA1 subunit (<italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice) to investigate GluA1-independent mechanisms of LTP at CA3&#x02013;CA1 synapses in transverse hippocampal slices. An extracellular, paired theta-burst stimulation paradigm induced a robust GluA1-independent form of LTP lacking the early, rapidly decaying component characteristic of LTP in wild-type mice. This GluA1-independent form of LTP was attenuated by inhibitors of neuronal nitric oxide synthase and protein kinase C (PKC), two enzymes known to regulate GluA2 surface expression. Furthermore, the induction of GluA1-independent potentiation required the activation of GluN2B (NR2B) subunit-containing NMDA receptors. Our findings support and extend the evidence that LTP at hippocampal CA3&#x02013;CA1 synapses comprises a rapidly decaying, GluA1-dependent component and a more sustained, GluA1-independent component, induced and expressed via a separate mechanism involving GluN2B-containing NMDA receptors, neuronal nitric oxide synthase and PKC.</p></abstract><kwd-group><kwd>glutamate receptor</kwd><kwd>mouse</kwd><kwd>synaptic plasticity</kwd></kwd-group></article-meta></front><body><sec><title>Introduction</title><p>An eagerly discussed question in neuroscience is whether long-term potentiation (LTP; <xref ref-type="bibr" rid="b8">Bliss &#x00026; L&#x000f8;mo, 1973</xref>;<xref ref-type="bibr" rid="b7">Bliss &#x00026; Collingridge, 1993</xref>) engages the same neural mechanisms that are responsible for learning and memory (<xref ref-type="bibr" rid="b48">Martin <italic>et al.</italic>, 2000</xref>; <xref ref-type="bibr" rid="b47">Martin &#x00026; Morris, 2002</xref>). However, the complex mechanisms underlying LTP are still not completely understood. Conventional hippocampal CA3&#x02013;CA1 LTP (<xref ref-type="bibr" rid="b7">Bliss &#x00026; Collingridge, 1993</xref>) is believed to be expressed, at least in part, by an increase in synaptic &#x003b1;-amino-3-hydroxy-5-methyl-4-isoxazole proprionic acid (AMPA) receptors (AMPAR). Most AMPAR in hippocampal neurons are heterodimers composed of either GluA1/GluA2 or GluA2/GluA3 subunit combinations (<xref ref-type="bibr" rid="b76">Wenthold <italic>et al.</italic>, 1996</xref>), using the new subunit nomenclature recommended by the International Union of Basic and Clinical Pharmacology (IUPHAR). Accordingly, AMPAR subunits earlier known as either GluR-A, B, C and D, or GluR1, 2, 3 and 4, are renamed GluA1, GluA2, GluA3 and GluA4, and the corresponding mouse genes are <italic>Gria1</italic>, <italic>Gria2</italic>, <italic>Gria3</italic> and <italic>Gria4</italic> (<xref ref-type="bibr" rid="b15">Collingridge <italic>et al.</italic>, 2009</xref>). In an influential study, <xref ref-type="bibr" rid="b65">Shi <italic>et al.</italic> (2001)</xref> suggested that LTP is mediated by an activity-regulated increase in synaptic GluA1-containing AMPAR. Consistent with this suggestion, <xref ref-type="bibr" rid="b78">Zamanillo <italic>et al.</italic> (1999)</xref> reported that LTP is absent in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice and concluded that the GluA1 subunit is an absolute requirement for tetanus-induced CA3&#x02013;CA1 LTP.</p><p>In contrast to GluA1/GluA2 AMPAR, GluA2/GluA3 AMPAR are thought to constitutively cycle in and out of the synapse (<xref ref-type="bibr" rid="b65">Shi <italic>et al.</italic>, 2001</xref>). However, increasing evidence suggests that the constitutive recycling of GluA2-containing AMPAR might not be that passive after all: <xref ref-type="bibr" rid="b17">Daw <italic>et al.</italic> (2000)</xref> found that GluA2 surface expression is regulated by a protein kinase C (PKC)-dependent mechanism, and regulated insertion of GluA2 might be critical for the longer-term expression and maintenance of LTP in the hippocampus (<xref ref-type="bibr" rid="b21">Gardner <italic>et al.</italic>, 2005</xref>; <xref ref-type="bibr" rid="b68">Sossa <italic>et al.</italic>, 2007</xref>; <xref ref-type="bibr" rid="b77">Yao <italic>et al.</italic>, 2008</xref>). Furthermore, activity-driven GluA2 insertion mediates a form of LTP in the cerebellum (<xref ref-type="bibr" rid="b32">Kakegawa &#x00026; Yuzaki, 2005</xref>), where the increase of GluA2-containing AMPAR is regulated by nitric oxide (<xref ref-type="bibr" rid="b29">Huang <italic>et al.</italic>, 2005</xref>), produced by neuronal nitric oxide synthase (nNOS) upon <italic>N</italic>-methyl-<sc>d</sc>-aspartate (NMDA) receptor (NMDAR) activation (<xref ref-type="bibr" rid="b10">Bredt &#x00026; Snyder, 1989</xref>; <xref ref-type="bibr" rid="b22">Garthwaite <italic>et al.</italic>, 1989</xref>; <xref ref-type="bibr" rid="b11">Brenman &#x00026; Bredt, 1997</xref>). A similar, nitric oxide-regulated surface expression of GluA2 has recently been reported in cultured hippocampal neurons (<xref ref-type="bibr" rid="b67">Sossa <italic>et al.</italic>, 2006</xref>, <xref ref-type="bibr" rid="b68">2007</xref>). Moreover, <xref ref-type="bibr" rid="b26">Hoffman <italic>et al.</italic> (2002)</xref> provided initial evidence that hippocampal LTP can be expressed without the GluA1 subunit: a theta-burst induction paradigm revealed a gradually developing form of LTP in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice. However, the precise mechanisms underlying this GluA1-independent form of hippocampal LTP remained unclear.</p><p>We used extracellular field recordings from hippocampal slices of <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice (<xref ref-type="bibr" rid="b78">Zamanillo <italic>et al.</italic>, 1999</xref>) to study the cellular mechanisms of GluA1-independent CA3&#x02013;CA1 LTP. Extracellular, paired theta-burst stimulation induced robust LTP in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice without the early, rapidly decaying component characteristic of LTP in wild-type mice. Induction of GluA1-independent LTP specifically required the GluN2B (NR2B) NMDAR subunit. Moreover, GluA1-independent LTP was abolished by inhibitors of nNOS and PKC, two enzymes that participate in the activity-regulated insertion of GluA2-containing AMPAR (<xref ref-type="bibr" rid="b17">Daw <italic>et al.</italic>, 2000</xref>; <xref ref-type="bibr" rid="b56">Perez <italic>et al.</italic>, 2001</xref>; <xref ref-type="bibr" rid="b29">Huang <italic>et al.</italic>, 2005</xref>; <xref ref-type="bibr" rid="b67">Sossa <italic>et al.</italic>, 2006</xref>, <xref ref-type="bibr" rid="b68">2007</xref>). Our data extend the evidence that CA3&#x02013;CA1 LTP comprises a rapidly decaying, GluA1-dependent phase and a more sustained, GluA1-independent phase induced and expressed through a separate, GluN2B-, nNOS- and PKC-dependent mechanism.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><sec><title>Mice</title><p>All animal care and procedures described below were in compliance with the UK Home Office Project and Personal licenses held by the authors in accordance with Home Office regulations under the Animals (Scientific Procedures) Act of 1986.</p><p><italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice were created on a hybrid C57BL/6/129sv background (<xref ref-type="bibr" rid="b78">Zamanillo <italic>et al.</italic>, 1999</xref>). Several <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> breeding pairs (<italic>&#x0003e;</italic>F4) were transported to the UK and backcrossed to C57BL/6. For experimental cohorts of wild-type and <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice, <italic>Gria1</italic><sup>+/&#x02212;</sup> mice were intercrossed on-site in the departmental animal holding facility. Mice were housed in groups of two&#x02013;six with <italic>ad libitum</italic> access to food and water on a 12 : 12 h dark : light cycle at a temperature of &#x0223c;22 <italic>&#x000b0;</italic>C and a humidity of 60&#x02013;70%. For the following experiments, only male mice were used to avoid variations due to physiological differences between sexes.</p></sec><sec><title>Slice preparation</title><p>Horizontal hippocampal slices (350 &#x003bc;m) were prepared from adult male <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice of at least 6 months of age and their male wild-type littermates, after decapitation following isoflurane-induced anaesthesia (Isocare, Animalcare, York, UK) in a desiccator (0.5 mL isoflurane, until breathing slowed down to approximately one breath per second, and stimulation of the limb withdrawal reflex no longer elicited a response). Slices were stored at 34 &#x000b0;C in an interface recording chamber, and superfused (2 mL/min) with artificial cerebrospinal fluid (aCSF) of the following composition (in m<sc>m</sc>): NaCl, 126; KCl, 3; NaH<sub>2</sub>PO<sub>4</sub>, 1.25; MgSO<sub>4</sub>, 2; CaCl<sub>2</sub>, 2; NaHCO<sub>3</sub>, 26; glucose, 10; bubbled with carbogen gas (95% O<sub>2</sub>&#x02013;5% CO<sub>2</sub>) to pH 7.2&#x02013;7.4.</p></sec><sec><title>Electrophysiological protocols</title><p>Extracellular field recordings from CA1 were made with an Axoclamp-2A amplifier (Axon Instruments, Union City, CA, USA) in bridge mode. Glass recording electrodes were pulled from standard wall borosilicate tubing (4&#x02013;6 M&#x003a9;) and filled with aCSF. Recording and stimulation electrodes were positioned in CA1 with the aid of a stereoscope (<xref ref-type="fig" rid="fig01">Fig. 1A</xref>).</p><fig id="fig01" position="float"><label>Fig. 1</label><caption><p>Position of electrodes and LTP induction paradigm. (A) Diagram of a transverse hippocampal slice showing the position of stimulation and recording electrodes. (B) Schematic illustration of the paired theta-burst stimulation (pTBS) LTP induction paradigm.</p></caption><graphic xlink:href="ejn0029-1141-f1"/></fig><p>Blind patch-clamp recordings (<xref ref-type="bibr" rid="b13">Casta&#x000f1;eda-Castellanos <italic>et al.</italic>, 2006</xref>) were made from CA1 pyramidal neurons with a Multiclamp 700B amplifier (Axon Instruments) in current-clamp mode. Patch pipettes (6&#x02013;8 M&#x003a9;) were pulled from standard wall borosilicate tubing and filled with a solution containing (in m<sc>m</sc>): potassium gluconate, 110; HEPES, 40; NaCl, 4; ATP-Mg, 4; biocytin; GTP, 0.3; pH 7.2&#x02013;7.3. The patch pipette was positioned just above the surface of the pyramidal cell layer of CA1 under visual guidance and then slowly lowered while constantly monitoring the current during voltage-clamp, in response to a test voltage step. Once whole-cell configuration was achieved, cells were recorded in current-clamp. Pyramidal neurons were identified according to their firing pattern and by biocytin labelling after the experiment, following standard procedures as described by <xref ref-type="bibr" rid="b54">Oren <italic>et al.</italic> (2006)</xref>.</p><p>Synaptic efficacy was monitored in two independent afferent Schaffer collateral pathways stimulated alternately, each at 0.1 Hz (50 &#x003bc;s, 10&#x02013;100 &#x003bc;A), with monopolar tungsten electrodes placed either side of the recording electrode (<xref ref-type="fig" rid="fig01">Fig. 1A</xref>). For field recordings, a stimulus&#x02013;response curve [10&#x02013;100 &#x003bc;A stimulation strength, mean of five field excitatory postsynaptic potentials (fEPSPs) at each stimulation strength] was established and the stimulation strength subsequently set to elicit an fEPSP of half-maximal amplitude in wild-type mice and the corresponding amplitude in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice (70% of the half-maximal amplitude; <xref ref-type="fig" rid="fig02">Fig. 2B</xref>). The basal stimulation strength during whole-cell recording from individual pyramidal neurons was adjusted to evoke an EPSP peak amplitude of 5&#x02013;10 mV in both genotypes. fEPSP or EPSP rising slopes (middle third of the rising phase, before the action potential threshold) were monitored for a baseline period of 20 min. If synaptic transmission was stable (&#x0003c; 20% change in fEPSP or EPSP slopes over 20 min), one of the two Schaffer collateral pathways was stimulated with either a tetanic (100 Hz for 1 s) or paired theta-burst LTP induction paradigm (<xref ref-type="fig" rid="fig01">Fig. 1B</xref>). The other pathway served as a control and was not stimulated during the induction protocol. For paired theta-burst stimulation, the intensity of the stimulus delivered through the third electrode in the alveus was adjusted to a level just sufficient to elicit an antidromic population spike at the recording site.</p><fig id="fig02" position="float"><label>Fig. 2</label><caption><p>Synaptic transmission in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice. (A) Representative CA1 field excitatory postsynaptic potentials (EPSPs) in slices from a wild-type mouse (top left) and a <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mouse (bottom left), and mean presynaptic fibre volley (pv) and fEPSP amplitudes elicited by a single rectangular current pulse (50 &#x003bc;s at 70 &#x003bc;A) in the stratum radiatum among the Schaffer collaterals (wild-type, <italic>n</italic>=13; <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup>, <italic>n</italic>=21), ***<italic>P</italic>&#x0003c;0.001 (<sc>anova</sc>). (B) Stimulation strength&#x02013;response curves for wild-type (<italic>n</italic>=24) and <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice (<italic>n</italic>=26). To compensate for reduced synaptic transmission in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice, the baseline stimulation strength for wild-type and <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice in subsequent experiments was set to elicit an fEPSP of 50% and 70% of the maximal fEPSP amplitude, respectively. (C) Example traces of paired-pulse responses (left, 40-ms stimulus interval) and mean PPR in wild-type (<italic>n</italic>=6) and <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice (<italic>n</italic>=5). Data are presented as mean &#x000b1; SEM.</p></caption><graphic xlink:href="ejn0029-1141-f2"/></fig><p>In order to measure paired-pulse ratio (PPR), two 50-&#x003bc;s pulses with an inter-pulse interval of 40 ms were given at a stimulation strength eliciting half-maximal fEPSP amplitude in response to the first stimulus. The protocol was repeated five times at 0.1 Hz.</p></sec><sec><title>Pharmacology</title><p>Drugs were applied to the superfusate for at least 30 min (at least 1 h for intracellularly acting drugs) before the onset of baseline recording. To block NMDAR irrespective of GluN2 subunit composition, 30 &#x003bc;<sc>m</sc> 3-(R-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP; Tocris Biosciences, Bristol, UK) was applied to the superfusate. GluN2B-containing NMDAR were targeted by the ifenprodil-derivative (<italic>&#x003b1;R,&#x003b2;S</italic>)-&#x003b1;-(5-hydroxyphenyl)-&#x003b2;-methyl-4-(phenylmethyl)-1-piperidinepropanol (Ro 25-6981; Tocris; <xref ref-type="bibr" rid="b20">Fischer <italic>et al.</italic>, 1997</xref>), whereas (<italic>R</italic>)-[(<italic>S</italic>)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl-phosphonic acid (NVP-AAM077; kindly provided by Dr Y. Auberson, Novartis AG, Switzerland; <xref ref-type="bibr" rid="b2">Auberson <italic>et al.</italic>, 2002</xref>) was used to inhibit GluN2A-containing NMDA receptors. To block Ca<sup>2+</sup>/calmodulin-dependent protein kinase (CaM kinase), 1 &#x003bc;<sc>m</sc> 4-[(2<italic>S</italic>)-2-[(5-isoquinolinylsulphonyl) methylamino]-3-oxo-3-(4-phenyl-1-piperazinyl)propyl] phenylisoquinolinesulphonic acid ester (KN-62; Tocris; <xref ref-type="bibr" rid="b73">Tokumitsu <italic>et al.,</italic> 1990</xref>) was added to the superfusate. PKC was inhibited using 2 &#x003bc;<sc>m</sc> 1,2-dimethoxy-12-methyl[1,3]benzodioxolo[5,6-c]phenanthridinium (chelerythrine; Tocris; <xref ref-type="bibr" rid="b25">Herbert <italic>et al.</italic>, 1990)</xref>, which shows some selectivity for the atypical isoform protein kinase M&#x003b6; (PKM&#x003b6;) over other PKC isoforms at this concentration (<xref ref-type="bibr" rid="b38">Ling <italic>et al.</italic>, 2002</xref>). To inhibit nNOS, either 100 &#x003bc;<sc>m</sc> of the membrane-permeable inhibitor (4S)-<italic>N</italic>-(4-amino-5[aminoethyl]aminopentyl)-<italic>N</italic>&#x02032;-nitroguanidine (nNOS inhibitor I; Merck Biosciences, Nottingham, UK; <xref ref-type="bibr" rid="b23">Hah <italic>et al.</italic>, 2001</xref>) or 0.2 &#x003bc;<sc>m</sc> of vinyl-L<italic>-N-</italic>5-(1-imino-3-butenyl)-L-ornithine (L-VNIO; Alexis, Nottingham, UK), another NOS inhibitor with a high selectivity for nNOS (<xref ref-type="bibr" rid="b27">Hopper &#x00026; Garthwaite, 2006</xref>), were applied to the aCSF. Unlike other drugs, nNOS inhibitors were added to the aCSF during dissection, slice preparation and throughout the recovery period in order to allow sufficient time for the drug to reach its intracellular target.</p></sec><sec><title>Data analysis</title><p>Data acquisition and subsequent analysis were performed using Igor Pro (WaveMetrics, Lake Oswego, OR, USA), and statistical analysis was performed using <sc>spss</sc> software (SPSS, Chicago, IL, USA). Changes in synaptic efficacy were estimated by using the mean fEPSP or EPSP rising slopes of a specified 5-min period expressed as a percentage of the mean fEPSP or EPSP rising slope from the 5-min baseline period immediately before the LTP induction paradigm was delivered. PPR was expressed as the mean ratio of the rising slope of the second fEPSP to the rising slope of the first fEPSP in % (average of five paired pulses). All values are given as mean &#x000b1; SEM, and statistical significance was assessed using the Student&#x02019;s two-tailed <italic>t</italic>-test, <sc>anova</sc> and repeated-measures (RM) <sc>anova</sc>, followed by a <italic>post hoc</italic> analysis of simple main effects where applicable, using Sidak&#x02019;s adjustments for multiple comparisons. Numbers (<italic>n</italic>) refer to the number of mice.</p></sec></sec><sec><title>Results</title><sec><title>Gria1<sup>&#x02212;/&#x02212;</sup><italic>mice show attenuated synaptic transmission at CA3&#x02013;CA1 synapses</italic></title><p>To compare synaptic transmission at CA3&#x02013;CA1 synapses in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> and wild-type mice, extracellular field recordings from the stratum radiatum of CA1 were made while stimulating the Schaffer collateral pathway with 50-&#x003bc;s current pulses at various amplitudes. In response to single 70-&#x003bc;A current pulses, the mean fEPSP in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice reached only 65% of the mean fEPSP amplitude in wild-type mice (<xref ref-type="fig" rid="fig02">Fig. 2A</xref>; one-way <sc>anova</sc>, <italic>F</italic><sub>1,32</sub> = 19.6, <italic>P</italic>&#x0003c;0.001). The smaller fEPSP amplitudes in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice were observed across a range of stimulation strengths from 10 to 100 &#x003bc;A (<xref ref-type="fig" rid="fig02">Fig. 2B</xref>; RM <sc>anova</sc>, main effect of genotype <italic>F</italic><sub>1,48</sub> = 11.7, <italic>P &#x0003c;</italic>0.005, genotype by stimulation strength interaction <italic>F</italic><sub>9,432</sub> = 5.8, <italic>P &#x0003c;</italic>0.05). The smaller fEPSP amplitude in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice could not be attributed to a reduction in fibre excitability, as the presynaptic fibre volley amplitudes were almost identical between the genotypes (<xref ref-type="fig" rid="fig02">Fig. 2A</xref>; one-way <sc>anova</sc>, <italic>F &#x0003c;</italic>1). Moreover, a comparison of PPRs in wild-type and <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice showed no significant differences between genotypes and thus provided no evidence for an alteration of presynaptic signalling in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice (<xref ref-type="fig" rid="fig02">Fig. 2C</xref>; stimulus duration 50 &#x003bc;s, inter-stimulus interval 40 ms, at 70 &#x003bc;A, one-way <sc>anova</sc> of PPR, <italic>F</italic>&#x0003c;1; see also <xref ref-type="bibr" rid="b78">Zamanillo <italic>et al.</italic>, 1999</xref>). Hence, with equivalent presynaptic activation, the postsynaptic response was significantly smaller in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice. This result suggests that a higher stimulation strength is needed to produce a postsynaptic excitatory current in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice equivalent to that in wild-type mice. In the following experiments, the stimulation strength for monitoring basal synaptic transmission and for induction of LTP in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice was therefore set to 70% of the maximal amplitude, roughly corresponding to 50% of the maximal amplitude in wild-type mice (<xref ref-type="fig" rid="fig02">Fig. 2B</xref>).</p></sec><sec><title>Extracellular paired theta-burst stimulation induces a robust GluA1-independent form of LTP</title><p>To induce CA3&#x02013;CA1 LTP in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice, we adapted the intracellular theta-burst paradigm previously described by <xref ref-type="bibr" rid="b26">Hoffman <italic>et al.</italic> (2002)</xref> for extracellular field recordings. After stable baseline synaptic transmission for at least 20 min, one of the two Schaffer collateral input pathways was stimulated with a theta-burst paradigm that was paired, with a small temporal offset, with an identical theta-burst paradigm applied to the alveus of CA1 (pTBS; <xref ref-type="fig" rid="fig01">Fig. 1A and B</xref>). The rationale for this pairing paradigm was to elicit synaptic events coinciding with backpropagating action potentials in the postsynaptic neuronal population.</p><p>pTBS of the Schaffer collateral input/alveus induced significant LTP in wild-type mice (potentiation after 45 min: 150 &#x000b1; 10%, Student&#x02019;s <italic>t</italic>-test, <italic>t</italic>=4.0, <italic>P</italic>&#x0003c;0.05) as well as <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice (154 &#x000b1; 15%, <italic>t</italic>=3.6, <italic>P</italic>&#x0003c;0.01), whereas no fEPSP slope changes were observed in the unpaired control pathway (wild-type: 100 &#x000b1; 5%, <italic>t</italic>&#x0003c;1; <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup>: 105 &#x000b1; 4%, <italic>t</italic>&#x0003c;1; <xref ref-type="fig" rid="fig03">Fig. 3A</xref>). However, the absence of an early, rapidly decaying component of potentiation readily distinguished LTP in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice from potentiation in their wild-type littermates. Despite this difference in the early potentiation, fEPSPs in both genotypes reached the same level of potentiation 45 min after induction. In order to compare the time course and amount of pTBS-induced potentiation in wild-type and <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice, a RM <sc>anova</sc> was conducted on the normalised fEPSP slopes immediately (0&#x02013;5 min), 15&#x02013;20 min and 45&#x02013;50 min after induction in both genotypes. The <sc>anova</sc> revealed no main effect of genotype (<italic>F</italic>&#x0003c;1), a main effect of time (<italic>F</italic><sub>2,24</sub> = 6.5, <italic>P</italic>&#x0003c;0.05), and a significant interaction of time and genotype (<italic>F</italic><sub>2,24</sub> = 8.9, <italic>P</italic>&#x0003c;0.01). A <italic>post hoc</italic> analysis of the simple main effects of genotype at each individual time point confirmed that the amount of potentiation in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> and wild-type mice differed immediately after pTBS (<italic>F</italic><sub>1,12</sub> = 12.7, <italic>P</italic>&#x0003c;0.001), but not 15 min or 45 min after induction (both <italic>F</italic>&#x0003c;1).</p><fig id="fig03" position="float"><label>Fig. 3</label><caption><p>Hippocampal CA3&#x02013;CA1 LTP in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> and wild-type mice. (A) Mean paired theta-burst stimulation (pTBS)-induced LTP of field excitatory postsynaptic potentials (fEPSPs) in (i) wild-type (<italic>n</italic>=6) and (ii) <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice (<italic>n</italic>=8). The insets show example traces of the paired (left) and control pathways (right) before (grey) and 45 min after pTBS (black). (iii) Normalised fEPSP slope in each individual slice 45 min after pTBS in paired (open symbols) and control pathway (filled symbols). (B) The same paradigm induced input-specific LTP of EPSPs in individual CA1 pyramidal neurons of both (i) wild-type (<italic>n</italic>=4), and (ii) <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice (<italic>n</italic>=5). The insets show example traces of the paired (left) and control pathways (right) before (grey) and 45 min after pTBS (black). (iii) Normalised EPSP slope in each individual cell 45 min after pTBS.</p></caption><graphic xlink:href="ejn0029-1141-f3"/></fig><p>Although pTBS-induced LTP was pathway specific when observed with extracellular field recordings, the intracellular theta-burst stimulation originally used to induce GluA1-independent potentiation not only potentiated the EPSP in the paired pathway, but also caused a significant increase of EPSP amplitude in the control pathway (<xref ref-type="bibr" rid="b26">Hoffman <italic>et al.</italic>, 2002</xref>). Therefore, in order to test whether the GluA1-independent potentiation we observed with field recordings is a pathway-specific form of LTP also at the single-cell level, we recorded from individual pyramidal neurons in whole-cell mode and applied pTBS under experimental conditions identical to those described above for field recordings.</p><p>Firing patterns and <italic>post hoc</italic> biocytin labelling confirmed that the cells we recorded from were pyramidal neurons. As observed with field recordings, pTBS of the Schaffer collaterals/alveus induced similar amounts of LTP in CA1 pyramidal cells of <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice (potentiation after 40 min: 181 &#x000b1; 27%; Student&#x02019;s <italic>t</italic>-test: <italic>t</italic>=3.9, <italic>P</italic>&#x0003c;0.05) and their wild-type littermates (potentiation after 40 min: 184 &#x000b1; 27%; <italic>t</italic>=3.4, <italic>P</italic>&#x0003c;0.05; <xref ref-type="fig" rid="fig03">Fig. 3B</xref>). In both genotypes, LTP was observed only in the paired pathway, with no significant change in the control pathway in either wild-type (85 &#x000b1; 17%, <italic>t</italic>&#x0003c;1) or <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice (111 &#x000b1; 5%, <italic>t</italic>&#x0003c;1). Intracellular, GluA1-independent LTP showed the same characteristic lack of an initial, rapidly decaying potentiation as LTP recorded in the field, and eventually reached the same level as intracellular LTP in wild-type mice. A RM <sc>anova</sc> comparing EPSP potentiation in the two genotypes immediately, and 40 min after induction, revealed no main effect of genotype or time (all <italic>F</italic>&#x0003c;2.5, <italic>P</italic>&#x0003e;0.10), but a significant genotype by time interaction (<italic>F</italic><sub>1,8</sub> = 25.8, <italic>P</italic>&#x0003c;0.005). A <italic>post hoc</italic> analysis of simple main effects showed a significant difference in the magnitude of potentiation between wild-type and <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice immediately after pTBS (<italic>F</italic><sub>1,8</sub> = 6.1, <italic>P</italic>&#x0003c;0.05), but not 40 min after induction (<italic>F</italic>&#x0003c;1.4, <italic>P</italic>&#x0003e;0.20). Hence, both single-cell and field recordings show that the GluA1 subunit is not obligatory for input-specific LTP at Schaffer collateral&#x02013;CA1 pyramidal cell synapses.</p></sec><sec><title>A single weak tetanus is not sufficient to induce GluA1-independent LTP</title><p>Because previous studies reported a lack of LTP in adult <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice (<xref ref-type="bibr" rid="b78">Zamanillo <italic>et al.</italic>, 1999</xref>; <xref ref-type="bibr" rid="b30">Jensen <italic>et al.</italic>, 2003</xref>), we also tested whether a single 100-Hz tetanus, as used by <xref ref-type="bibr" rid="b78">Zamanillo <italic>et al.</italic> (1999)</xref>, would be sufficient to induce GluA1-independent LTP. Although this weaker induction paradigm led to small but significant LTP in wild-type mice (potentiation 45 min after induction: 135 &#x000b1; 13%, <italic>t</italic>=2.65, <italic>P</italic>&#x0003c;0.05), no significant potentiation developed in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice (105 &#x000b1; 10%, <italic>t</italic>&#x0003c;1; <xref ref-type="fig" rid="fig04">Fig. 4</xref>), which suggests that GluA1-independent LTP and GluA1-dependent potentiation have distinct induction properties.</p><fig id="fig04" position="float"><label>Fig. 4</label><caption><p>A single weak tetanus is not sufficient to induce LTP in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice. (A) Mean potentiation in wild-type (<italic>n</italic>=6) and <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice (<italic>n</italic>=5) after a single tetanus to the Schaffer collateral pathway. Data are presented as mean &#x000b1; SEM. (B) Normalised field excitatory postsynaptic potential (fEPSP) slope in each individual slice 45 min after the tetanus in wild-type (circles) and <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice (squares).</p></caption><graphic xlink:href="ejn0029-1141-f4"/></fig></sec><sec><title>PPRs give no evidence for a presynaptic expression mechanism of GluA1-independent LTP</title><p>Both pre- and postsynaptic mechanisms can contribute to the expression of long-lasting changes in synaptic efficacy (see <xref ref-type="bibr" rid="b44">Malenka &#x00026; Bear, 2004</xref>). Because the GluA1 subunit is important for several mechanisms implicated in postsynaptic LTP expression (<xref ref-type="bibr" rid="b5">Benke <italic>et al.</italic>, 1998</xref>; <xref ref-type="bibr" rid="b18">Derkach <italic>et al.</italic>, 1999</xref>; <xref ref-type="bibr" rid="b24">Hayashi <italic>et al.</italic>, 2000</xref>; <xref ref-type="bibr" rid="b65">Shi <italic>et al.</italic>, 2001</xref>; <xref ref-type="bibr" rid="b58">Piccini &#x00026; Malinow, 2002</xref>; <xref ref-type="bibr" rid="b9">Boehm <italic>et al.</italic>, 2006</xref>; <xref ref-type="bibr" rid="b53">Oh <italic>et al.</italic>, 2006</xref>), it is possible that GluA1-independent LTP could be expressed presynaptically. A decrease in the PPR after LTP induction is commonly used to argue for the recruitment of presynaptic expression mechanism(s), because a presynaptic expression mechanism mediated by an increased probability of presynaptic transmitter release would leave less capacity for paired-pulse facilitation (<xref ref-type="bibr" rid="b49">McNaughton, 1982</xref>; <xref ref-type="bibr" rid="b79">Zucker &#x00026; Regehr, 2002</xref>). However, neither GluA1-independent LTP nor LTP in wild-type mice was accompanied by a change in PPR (<italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup>: 140 &#x000b1; 4% before pTBS, 141 &#x000b1; 9% 45 min after pTBS; wild-type: 143 &#x000b1; 4% before pTBS, 138 &#x000b1; 5% 45 min after pTBS, RM <sc>anova</sc> all <italic>F</italic>&#x0003c;1). Thus, analysis of PPR provides no evidence for a presynaptic locus of expression of GluA1-independent LTP at hippocampal CA3&#x02013;CA1 synapses.</p></sec><sec><title>The induction of GluA1-independent LTP requires activation of GluN2B subunit-containing NMDAR</title><p>Because GluA1-independent LTP can be induced with a theta-burst pairing paradigm, but does not occur after a single weak tetanus, we investigated whether distinct NMDAR subunits are involved in the induction of GluA1-independent LTP mechanisms. At hippocampal synapses, NMDAR form GluN1/GluN2A, GluN1/GluN2B and GluN1/GluN2A/GluN2B heteromers (<xref ref-type="bibr" rid="b50">Monyer <italic>et al.</italic>, 1994</xref>; <xref ref-type="bibr" rid="b16">Cull-Candy <italic>et al.</italic>, 2001</xref>; <xref ref-type="bibr" rid="b34">K&#x000f6;hr, 2006</xref>), and recent evidence suggests that GluN2A and GluN2B subunits are linked to distinct intracellular signalling cascades (<xref ref-type="bibr" rid="b41">Liu <italic>et al.</italic>, 2004</xref>; <xref ref-type="bibr" rid="b3">Barria &#x00026; Malinow, 2005</xref>; <xref ref-type="bibr" rid="b33">Kim <italic>et al.</italic>, 2005</xref>).</p><p>First, we tested whether pTBS-induced, GluA1-independent LTP and LTP in wild-type mice are similarly affected by the general NMDAR antagonist CPP (30 &#x003bc;<sc>m</sc>). As previously described by <xref ref-type="bibr" rid="b26">Hoffman <italic>et al.</italic> (2002)</xref> for the intracellular GluA1-independent LTP, the inhibition of NMDAR completely abolished the induction of GluA1-independent potentiation by an extracellular pTBS paradigm, as well as LTP in wild-type mice (<xref ref-type="fig" rid="fig05">Fig. 5A</xref>). A RM <sc>anova</sc> with drug as a between-subjects factor (CPP vs. control) and time as a within-subjects factor (0&#x02013;5 min and 45&#x02013;50 min after pTBS) for each genotype revealed a main effect of drug on LTP, both in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice (<italic>F</italic><sub>1,10</sub> = 49.2, <italic>P</italic>&#x0003c;0.005, drug by time interaction, <italic>F</italic><sub>1,10</sub> = 6.9, <italic>P</italic>&#x0003c;0.05), and in wild-type littermate controls (<italic>F</italic><sub>1,14</sub> = 21.4, <italic>P</italic>&#x0003c;0.001, main effect of time, <italic>F</italic><sub>1,14</sub> = 8.3, <italic>P</italic>&#x0003c;0.05, no further interactions, all <italic>F</italic>&#x0003c;1), which shows that NMDAR activation is necessary, both for the induction of the early, decaying phase of potentiation in wild-type mice and for GluA1-independent potentiation.</p><fig id="fig05" position="float"><label>Fig. 5</label><caption><p>GluA1-independent long-term potentiation (LTP) requires activation of GluN2B-containing NMDA receptors. (A) The NMDAR antagonist 3-(R-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP) blocked pTBS-induced LTP in wild-type (<italic>n</italic>=7, control <italic>n</italic>=9) and <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice (<italic>n</italic>=5, control <italic>n</italic>=7). (B) The GluN2B subunit-selective NMDAR antagonist (<italic>&#x003b1;R,&#x003b2;S</italic>)-&#x003b1;-(5-hydroxyphenyl)-&#x003b2;-methyl-4-(phenylmethyl)-1-piperidinepropanol (Ro 25-6981) had no effect on LTP in wild-type mice (<italic>n</italic>=9, control <italic>n</italic>=15), but attenuated LTP in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice (<italic>n</italic>=15, control <italic>n</italic>=11). (C) (<italic>R</italic>)-[(<italic>S</italic>)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl-phosphonic acid (NVP-AAM077) (50 n<sc>m</sc>) had no significant effect on either GluA1-independent LTP (<italic>n</italic>=6, control <italic>n</italic>=6) or LTP in wild-type mice (<italic>n</italic>=12, control <italic>n</italic>=8). NVP-AAM077 (400 n<sc>m</sc>) attenuated both GluA1-independent LTP (<italic>n</italic>=9) and LTP in wild-type mice (<italic>n</italic>=7). Data are presented as mean &#x000b1; SEM. fEPSP, field excitatory postsynaptic potential.</p></caption><graphic xlink:href="ejn0029-1141-f5"/></fig><p>To target GluN2B-containing NMDAR, we used the GluN2B subunit-selective compound Ro 25-6981 (<xref ref-type="bibr" rid="b20">Fischer <italic>et al.</italic>, 1997</xref>). Superfusion of 0.5 &#x003bc;<sc>m</sc> Ro 25-6981 for at least 1 h prior to pTBS had no effect on the induction of LTP in wild-type mice, and in particular did not affect the early, rapidly decaying phase [<xref ref-type="fig" rid="fig04">Fig. 4B</xref>; RM <sc>anova</sc> with drug condition (Ro 25-6981 vs. control) as a between-subjects factor and time (0&#x02013;5 min and 45&#x02013;50 min after pTBS) as a within-subject factor, no effect of drug or interactions involving drug, all <italic>F</italic>&#x0003c;1]. In contrast, Ro 25-6981 strongly reduced GluA1-independent LTP (<xref ref-type="fig" rid="fig05">Fig. 5B</xref>; main effect of drug, <italic>F</italic><sub>1,24</sub> = 27.7, <italic>P</italic>&#x0003c;0.005, drug by time interaction, <italic>F</italic><sub>1,24</sub> = 7.9, <italic>P &#x0003c;</italic>0.001). Thus, induction of LTP requires the activation of GluN2B-containing NMDAR in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice, whereas the GluN2B subunit does not appear to be required when GluA1 is present.</p><p>In the next set of experiments, slices were treated with the GluN2A subunit-preferring NMDAR antagonist NVP-AAM077 (<xref ref-type="bibr" rid="b2">Auberson <italic>et al.</italic>, 2002</xref>). Because the selective action of NVP-AAM077 is concentration-dependent (<xref ref-type="bibr" rid="b6">Berberich <italic>et al.</italic>, 2005</xref>; <xref ref-type="bibr" rid="b51">Neyton &#x00026; Paoletti, 2006</xref>), NVP-AAM077 was applied at two concentrations, 50 and 400 n<sc>m</sc>. In HEK293 cells expressing either GluN1/GluN2A- or GluN1/GluN2B-type rodent NMDAR, 50 n<sc>m</sc> NVP-AAM077 inhibits 77% of GluN2A-mediated NMDA receptor currents and 27% of GluN2B-mediated NMDA receptor currents, whereas 400 n<sc>m</sc> NVP-AAM077 blocks 97% of the GluN2A-mediated currents and 67% of GluN2B-mediated currents (<xref ref-type="bibr" rid="b6">Berberich <italic>et al.</italic>, 2005</xref>). When applied to the superfusate for at least 1 h prior to pTBS, 50 n<sc>m</sc> NVP-AAM077 had no overall effect on LTP in either wild-type or <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice (all <italic>F</italic>&#x0003c;1, see overall RM <sc>anova</sc> results below). Although not strictly appropriate in the absence of a significant drug by time interaction (<xref ref-type="bibr" rid="b28">Howell, 1997</xref>), a separate <italic>t</italic>-test comparing the early, possibly GluA1-dependent component of potentiation in wild-type mice with and without NVP-AAM077 revealed a significant effect of drug (<italic>t</italic>=3.8, <italic>P</italic>&#x0003c;0.05). NVP-AAM077 (400 n<sc>m</sc>) in the superfusate entirely prevented the induction of LTP in both genotypes (<xref ref-type="fig" rid="fig05">Fig. 5C</xref>). A RM <sc>anova</sc> with drug (0, 50 and 400 n<sc>m</sc> NVP-AAM077) as a between-subjects factor and time (0&#x02013;5 min and 45&#x02013;50 min after pTBS) as a within-subject factor for each genotype revealed a main effect of drug on LTP in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice (<italic>F</italic><sub>2,18</sub> = 5.8, <italic>P</italic>&#x0003c;0.001, no further effects or interactions, all <italic>F</italic>&#x0003c;2, <italic>P</italic>&#x0003e;0.2) and wild-type mice (<italic>F</italic><sub>2,24</sub> = 12.6, <italic>P</italic>&#x0003c;0.001; main effect of time, <italic>F</italic><sub>1,24</sub> = 10.7, <italic>P</italic>&#x0003c;0.005; no interactions, all <italic>F</italic>&#x0003c;2). A <italic>post hoc</italic> comparison of the effect of 50 n<sc>m</sc> NVP-AAM077 returned no significant effect of 50 n<sc>m</sc> NVP-AAM077 (<italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup>: <italic>F</italic>&#x0003c;1, <italic>P</italic>&#x0003e;0.1; wild-type: <italic>F</italic>&#x0003c;1, <italic>P</italic>&#x0003e;0.1), and no significant drug by time interaction (<italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup>: <italic>F</italic>&#x0003c;1, <italic>P</italic>&#x0003e;0.2; wild-type: <italic>F</italic>&#x0003c;1, <italic>P</italic>&#x0003e;0.1) in either genotype. In contrast, a <italic>post hoc</italic> comparison of the effect of 400 n<sc>m</sc> NVP-AAM077 revealed a significant effect on LTP in wild-type (<italic>F</italic><sub>1,24</sub> = 12.6, <italic>P</italic>&#x0003c;0.001) and <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice (<italic>F</italic><sub>1,18</sub> = 5.8, <italic>P</italic>&#x0003c;0.05).</p><p>Thus, only the early, possibly GluA1-dependent component of potentiation in wild-type mice was sensitive to NVP-AAM077 at low concentrations. The limited selectivity of NVP-AAM077 at higher concentrations prevented us from reaching a definitive conclusion about the contribution of GluN2A-containing NMDAR to induction of LTP in either genotype.</p></sec><sec><title>GluA1-independent LTP requires CaM kinase</title><p>Downstream of NMDAR activation, a transient rise in intracellular Ca<sup>2+</sup> levels is thought to be important for LTP induction (<xref ref-type="bibr" rid="b43">Lynch <italic>et al.</italic>, 1983</xref>; <xref ref-type="bibr" rid="b14">Collingridge <italic>et al.</italic>, 1992</xref>; <xref ref-type="bibr" rid="b60">Raymond &#x00026; Redman, 2002</xref>). The enzyme CaM kinase II (CaMKII) acts as a Ca<sup>2+</sup> sensor in the postsynaptic spine and is essential for LTP in wild-type mice (<xref ref-type="bibr" rid="b45">Malinow <italic>et al.</italic>, 1988</xref>, <xref ref-type="bibr" rid="b46">1989</xref>; <xref ref-type="bibr" rid="b66">Silva <italic>et al.</italic>, 1992</xref>). GluA1, which can be phosphorylated by CaMKII on the S831 residue (<xref ref-type="bibr" rid="b4">Barria <italic>et al.</italic>, 1997</xref>; <xref ref-type="bibr" rid="b35">Lee <italic>et al.</italic>, 2000</xref>), is among the many target proteins of CaMKII that have been implicated in synaptic plasticity. We therefore asked whether a CaM kinase is still required for LTP when GluA1 is absent. The CaM kinase inhibitor KN-62 (10 &#x003bc;<sc>m</sc>) was applied for at least 2 h prior to pTBS, and had no effect on basal synaptic transmission in either genotype (<xref ref-type="fig" rid="fig06">Fig. 6D</xref>; RM <sc>anova</sc><italic>F</italic>&#x0003c;1, <italic>P</italic>&#x0003e;0.3 for both genotypes). It completely abolished LTP in wild-type mice, and also attenuated LTP in their <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> littermates (<xref ref-type="fig" rid="fig06">Fig. 6A</xref>). A RM <sc>anova</sc> with drug (KN-62 vs. control) as a between-subjects factor and time (0&#x02013;5 min and 45&#x02013;50 min after pTBS) as a within-subject factor returned a main effect of drug on LTP in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> (<italic>F</italic><sub>1,11</sub> = 29.7, <italic>P</italic>&#x0003c;0.001, no further effects or interactions, all <italic>F</italic>&#x0003c;1.9, <italic>P</italic>&#x0003e;0.2) and wild-type mice (<italic>F</italic><sub>1,11</sub> = 13.1, <italic>P</italic>&#x0003c;0.005, main effect of time, <italic>F</italic><sub>1,11</sub> = 8.9, <italic>P</italic>&#x0003c;0.05, no interactions, all <italic>F</italic>&#x0003c;1). Thus, CaM kinase appears to be necessary for the induction of LTP regardless of whether or not the GluA1 subunit is present.</p><fig id="fig06" position="float"><label>Fig. 6</label><caption><p>GluA1-independent long-term potentiation (LTP) requires CaM kinase, neuronal nitric oxide synthase (nNOS) and PKC. (A) GluA1-independent LTP (<italic>n</italic>=9, control <italic>n</italic>=4) and wild-type LTP (<italic>n</italic>=7, control <italic>n</italic>=6) are both attenuated by the CaM kinase inhibitor 4-[(2<italic>S</italic>)-2-[(5-isoquinolinylsulphonyl)methylamino]-3-oxo-3-(4-phenyl-1-piperazinyl)propyl] phenylisoquinolinesulphonic acid ester (KN-62). (B) nNOS inhibitor I and L-VNIO had no effect on the early potentiation in wild-type mice (left, nNOSi I: <italic>n</italic>=12; L-VNIO: <italic>n</italic>=5; control: <italic>n</italic>=5), whereas they strongly reduced GluA1-independent LTP (right, nNOSi I: <italic>n</italic>=14; L-VNIO: <italic>n</italic>=5; control: <italic>n</italic>=6). (C) Chelerythrine (2 &#x003bc;<sc>m</sc>) reduced GluA1-independent LTP (right, <italic>n</italic>=8, control <italic>n</italic>=9), and the later phase of potentiation in wild-type mice (left, <italic>n</italic>=13, control <italic>n</italic>=10). (D) Stimulus&#x02013;response curves before and 3 h after application of CaM kinase, nNOS and PKC inhibitors in wild-type (left, KN-62: <italic>n</italic>=8; nNOSi I: <italic>n</italic>=9; chelerythrine: <italic>n</italic>=7) and <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice (right, KN-62: <italic>n</italic>=12; nNOSi I: <italic>n</italic>=7; chelerythrine: <italic>n</italic>=9). fEPSP, field excitatory postsynaptic potential.</p></caption><graphic xlink:href="ejn0029-1141-f6"/></fig></sec><sec><title>GluA1-independent LTP is mediated by a pathway involving nNOS and PKC</title><p>Although research on the expression mechanisms of LTP has focused mainly on the activity-driven synaptic insertion of GluA1 (<xref ref-type="bibr" rid="b65">Shi <italic>et al.</italic>, 2001</xref>), recent data from cultured cerebellar and hippocampal neurons have revealed a nitric oxide and <italic>N</italic>-ethylmaleimide-sensitive factor (NSF)-dependent pathway that leads to an increase in synaptic GluA2 subunits (<xref ref-type="bibr" rid="b29">Huang <italic>et al.</italic>, 2005</xref>; <xref ref-type="bibr" rid="b67">Sossa <italic>et al.</italic>, 2006</xref>, <xref ref-type="bibr" rid="b68">2007</xref>). In order to assess whether this, or a similar, pathway mediates the GluA1-independent form of LTP in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice, extracellular field recordings were performed in the presence of a potent, membrane-permeable inhibitor of nNOS, 100 &#x003bc;<sc>m</sc> nNOS inhibitor I. This inhibitor had no effect on basal synaptic transmission in either genotype (<xref ref-type="fig" rid="fig06">Fig. 6D</xref>; RM <sc>anova</sc>s, <italic>F</italic>&#x0003c;1, <italic>P</italic>&#x0003e;0.2 for both genotypes) or on the amplitude of pTBS-induced LTP in wild-type mice [<xref ref-type="fig" rid="fig06">Fig. 6B</xref>; RM <sc>anova</sc> with drug (nNOS inhibitor I vs. control) as a between-subjects factor and time (0&#x02013;5 min and 45&#x02013;50 min after pTBS) as a within-subject factor: main effect of time, <italic>F</italic><sub>1,15</sub> = 7.0, <italic>P</italic>&#x0003c;0.05, no main effect of drug or interactions, all <italic>F</italic>&#x0003c;1]. In contrast, nNOS inhibitor I significantly reduced the magnitude of potentiation in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice [<xref ref-type="fig" rid="fig06">Fig. 6B</xref>; RM <sc>anova</sc> with drug (nNOS inhibitor I vs. control) as a between-subjects factor and time (0&#x02013;5 min and 45&#x02013;50 min after pTBS) as a within-subject factor, main effect of drug, <italic>F</italic><sub>1,18</sub> = 5.7, <italic>P</italic>&#x0003c;0.05, no further effects or interactions, all <italic>F</italic>&#x0003c;2, <italic>P</italic>&#x0003e;0.1]. Similar results were obtained with a second nNOS inhibitor, L-VNIO (0.2 &#x003bc;<sc>m</sc>), which had no significant effect on the first 60 min of potentiation in wild-type mice (<xref ref-type="fig" rid="fig06">Fig. 6B</xref>; RM <sc>anova</sc>, no main effect of drug or interactions, all <italic>F</italic>&#x0003c;2, <italic>P</italic>&#x0003e;0.1), but significantly reduced LTP in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> animals [<xref ref-type="fig" rid="fig06">Fig. 6B</xref>; RM <sc>anova</sc> with drug (L-VNIO vs. control) as a between-subjects factor and time (0&#x02013;5 min and 45&#x02013;50 min after pTBS) as a within-subject factor, main effect of drug, <italic>F</italic><sub>1,9</sub> = 3.9, <italic>P</italic>&#x0003c;0.05, no further effects or interactions, all <italic>F</italic>&#x0003c;1, <italic>P</italic>&#x0003e;0.1]. It therefore appears that nNOS plays an important role in the induction of GluA1-independent LTP, which supports the hypothesis that this form of LTP might be mediated by an insertion of GluA2-containing AMPAR via a regulated nNOS and possibly NSF-dependent pathway (<xref ref-type="bibr" rid="b67">Sossa <italic>et al.</italic>, 2006</xref>, <xref ref-type="bibr" rid="b68">2007</xref>).</p><p>PKC is another protein involved in the synaptic trafficking of both GluA1 (<xref ref-type="bibr" rid="b9">Boehm <italic>et al.</italic>, 2006</xref>) and GluA2 AMPAR subunits (<xref ref-type="bibr" rid="b17">Daw <italic>et al.</italic>, 2000</xref>; <xref ref-type="bibr" rid="b56">Perez <italic>et al.</italic>, 2001</xref>), and particularly the PKM&#x003b6; isoform plays an important role in the later phases of LTP in wild-type mice (<xref ref-type="bibr" rid="b39">Ling <italic>et al.</italic>, 2006</xref>; <xref ref-type="bibr" rid="b77">Yao <italic>et al.</italic>, 2008</xref>). We therefore tested whether PKC activity is required for the GluA1-independent form of LTP. Inhibition of PKC with chelerythrine (2 &#x003bc;<sc>m</sc>), an inhibitor that, at low concentrations, shows a preference for PKM&#x003b6; over other PKC isoforms (<xref ref-type="bibr" rid="b38">Ling <italic>et al.</italic>, 2002</xref>), had no effect on basal synaptic transmission in either wild-type or <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice (<xref ref-type="fig" rid="fig06">Fig. 6D</xref>; RM <sc>anova</sc>s, <italic>F</italic>&#x0003c;1, <italic>P</italic>&#x0003e;0.2 for both genotypes). In wild-type mice, chelerythrine had no effect on the magnitude of the initial potentiation immediately after pTBS, but significantly reduced the magnitude of LTP 45 min after induction (<xref ref-type="fig" rid="fig06">Fig. 6C</xref>). A RM <sc>anova</sc> with drug (chelerythrine vs. control) as a between-subjects factor and time (0&#x02013;5 min and 45&#x02013;50 min after induction) as a within-subject factor returned no effect of drug (<italic>F</italic>&#x0003c;1), but a significant drug by time interaction (<italic>F</italic><sub>1,21</sub> = 9.5, <italic>P</italic>&#x0003c;0.005). A <italic>post hoc</italic> simple main effects analysis of the effect of chelerythrine at each time point confirmed that there was no effect on the early, rapidly decaying potentiation in wild-type mice (<italic>F</italic>&#x0003c;1). In contrast, LTP 45 min after induction was significantly reduced (<italic>F</italic><sub>1,21</sub> = 7.1, <italic>P</italic>&#x0003c;0.05). In <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice, chelerythrine (2 &#x003bc;<sc>m</sc>) strongly attenuated the overall level of potentiation [<xref ref-type="fig" rid="fig06">Fig. 6C</xref>; RM <sc>anova</sc> with drug (chelerythrine vs. control) as a between-subjects factor and time (0&#x02013;5 min and 45&#x02013;50 min after pTBS) as a within-subject factor, main effect of drug, <italic>F</italic><sub>1,15</sub> = 4.9, <italic>P</italic>&#x0003c;0.05, no further effects or interactions, all <italic>F</italic>&#x0003c;3.4, <italic>P</italic>&#x0003e;0.09]. Hence, both GluA1-independent LTP and the later phase of conventional LTP in wild-type mice require PKC, possibly the PKM&#x003b6; isoform.</p></sec></sec><sec><title>Discussion</title><sec><title>The role of GluA1 in LTP</title><p>It is well established that the GluA1 subunit is important for the expression of LTP. Phosphorylation of GluA1 has been shown to increase the conductance of AMPAR (<xref ref-type="bibr" rid="b5">Benke <italic>et al.</italic>, 1998</xref>; <xref ref-type="bibr" rid="b18">Derkach <italic>et al.</italic>, 1999</xref>), and the interaction of trafficking proteins and kinases with GluA1 regulates the activity-dependent surface expression of AMPAR (<xref ref-type="bibr" rid="b24">Hayashi <italic>et al.</italic>, 2000</xref>; <xref ref-type="bibr" rid="b42">Lu <italic>et al.</italic>, 2001</xref>; <xref ref-type="bibr" rid="b65">Shi <italic>et al.</italic>, 2001</xref>; <xref ref-type="bibr" rid="b58">Piccini &#x00026; Malinow, 2002</xref>). Furthermore, <xref ref-type="bibr" rid="b78">Zamanillo <italic>et al.</italic> (1999)</xref> previously reported that <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice did not express CA3&#x02013;CA1 LTP. However, this view has been challenged by <xref ref-type="bibr" rid="b26">Hoffman <italic>et al.</italic> (2002)</xref>, who provided initial evidence that a GluA1-independent form of potentiation can be expressed in these animals, when an intracellular, paired theta-burst induction protocol is used. Whereas the induction paradigm used by <xref ref-type="bibr" rid="b26">Hoffman <italic>et al.</italic> (2002)</xref> not only potentiated EPSPs in the paired pathway but also the unpaired control pathway, and the resulting, GluA1-independent potentiation developed gradually over 30 min, we have demonstrated here that extracellular pTBS can induce robust, input-specific, GluA1-independent LTP that is rapidly established within 5&#x02013;10 min. However, GluA1-independent LTP could not be induced with a single weak tetanus (also see <xref ref-type="bibr" rid="b78">Zamanillo <italic>et al.</italic>, 1999</xref>; <xref ref-type="bibr" rid="b30">Jensen <italic>et al.</italic>, 2003</xref>), and lacks the initial, rapidly decaying potentiation seen in wild-type mice. Thus, synaptic potentiation at CA3&#x02013;CA1 synapses appears to comprise a rapidly decaying, GluA1-dependent potentiation, and a more persistent, GluA1-independent potentiation that requires a stronger induction paradigm. Our initial findings raise the question about the extent to which induction and expression mechanisms of these two forms of potentiation are distinct or shared. We have established GluN2B-containing NMDAR, CaM kinase, PKC and nNOS as part of the signalling cascade that mediates GluA1-independent LTP. Of those, only CaM kinase was also required for the induction of the early, rapidly decaying, probably GluA1-dependent form of potentiation in wild-type mice. Although our findings are not sufficient to explain how GluA1-independent LTP is finally expressed, CaMKII, nNOS and PKC are known to regulate the activity-dependent, synaptic expression of AMPAR by interacting with the GluA2 subunit (<xref ref-type="bibr" rid="b17">Daw <italic>et al.</italic>, 2000</xref>; <xref ref-type="bibr" rid="b21">Gardner <italic>et al.</italic>, 2005</xref>; <xref ref-type="bibr" rid="b52">Oh &#x00026; Derkach, 2005</xref>; <xref ref-type="bibr" rid="b37">Lin &#x00026; Huganir, 2007</xref>; <xref ref-type="bibr" rid="b77">Yao <italic>et al.</italic>, 2008</xref>).</p></sec><sec><title>GluA1-independent LTP requires GluN2B-containing NMDAR</title><p>Both GluA1-independent LTP and LTP in wild-type mice are NMDAR dependent. Unlike LTP in wild-type mice, GluA1-independent LTP was strongly attenuated by the GluN2B subunit-selective NMDAR antagonist Ro 25-6981. Because GluN2B-containing NMDAR are preferentially, although not exclusively, located extrasynaptically (<xref ref-type="bibr" rid="b72">Stocca &#x00026; Vicini, 1998</xref>; <xref ref-type="bibr" rid="b74">Tovar &#x00026; Westbrook, 1999</xref>; <xref ref-type="bibr" rid="b71">Steigerwald <italic>et al.</italic>, 2000</xref>), and a single weak tetanus failed to induce LTP in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice, the induction of GluA1-independent LTP might require a more global Ca<sup>2+</sup> signal. Consistent with this possibility, <xref ref-type="bibr" rid="b26">Hoffman <italic>et al.</italic> (2002)</xref> found that the early, possibly GluA1-dependent phase of potentiation and the later, possibly GluA1-independent phase of LTP in wild-type mice are differentially sensitive to internal Ca<sup>2+</sup> buffers. Alternatively, or additionally, the relative synaptic GluN2B/GluN2A subunit composition might be different in the <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice, as has recently been described in <italic>Kv4.2</italic><sup>&#x02212;/&#x02212;</sup> mice (<xref ref-type="bibr" rid="b31">Jung <italic>et al.</italic>, 2008</xref>).</p><p>Although we show an important role of GluN2B-containing NMDAR in the induction of GluA1-independent LTP, the contribution of GluN2A-containing NMDAR remains uncertain. NVP-AAM077 (50 n<sc>m</sc>) had no effect on LTP in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice, but significantly reduced the early potentiation in wild-type mice, suggesting a more important role of GluN2A in this early, possibly GluA1-dependent potentiation. At the higher concentration used (400 n<sc>m</sc>), NVP-AAM077 blocked LTP in both genotypes, but does not distinguish between GluN2A- and GluN2B-containing receptors (<xref ref-type="bibr" rid="b6">Berberich <italic>et al.</italic>, 2005</xref>; <xref ref-type="bibr" rid="b51">Neyton &#x00026; Paoletti, 2006</xref>).</p></sec><sec><title>Downstream signalling in GluA1-independent LTP: CaM kinase, PKC and nNOS</title><p>The CaM kinase inhibitor KN-62 blocked GluA1-independent LTP and both the early and the later phases of LTP in wild-type mice. The necessity of CaMKII for at least the early phases of conventional LTP is well established (see <xref ref-type="bibr" rid="b40">Lisman <italic>et al.</italic>, 2002</xref>), but one of the main CaMKII target proteins implicated in this process is the GluA1 subunit (<xref ref-type="bibr" rid="b4">Barria <italic>et al.</italic>, 1997</xref>; <xref ref-type="bibr" rid="b5">Benke <italic>et al.</italic>, 1998</xref>; <xref ref-type="bibr" rid="b35">Lee <italic>et al.</italic>, 2000</xref>, <xref ref-type="bibr" rid="b36">2003</xref>). Our findings suggest that CaM kinase target proteins other than GluA1 are involved in the induction and/or expression of sustained GluA1-independent LTP. Interestingly, an interaction of CaMKII with the GluN2B NMDAR subunit has been reported to be necessary for pairing-induced LTP in wild-type mice (<xref ref-type="bibr" rid="b3">Barria &#x00026; Malinow, 2005</xref>). However, because KN-62 inhibits other CaM kinases in addition to CaMKII (<xref ref-type="bibr" rid="b19">Enslen <italic>et al.</italic>, 1994</xref>), we cannot attribute the effect of KN-62 to inhibition of CaMKII (<xref ref-type="bibr" rid="b75">Wayman <italic>et al.</italic>, 2008</xref>), and it is possible that the early phase of LTP and the GluA1-independent form of LTP are mediated by distinct members of the CaM kinase family.</p><p>We also showed that GluA1-independent LTP is attenuated by chelerythrine, a potent, cell-permeable PKC inhibitor that binds to the catalytic domain of PKC. Postsynaptic PKC is activated following strong NMDAR activation and release of Ca<sup>2+</sup> from intracellular stores, experimentally achieved by stronger, repetitive LTP induction paradigms (<xref ref-type="bibr" rid="b7">Bliss &#x00026; Collingridge, 1993</xref>; <xref ref-type="bibr" rid="b59">Raymond, 2007</xref>). Activated PKC has been shown to regulate synaptic AMPAR trafficking by phosphorylation of GluA1 (<xref ref-type="bibr" rid="b9">Boehm <italic>et al.</italic>, 2006</xref>) and AMPAR surface expression by phosphorylation of GluA2 (<xref ref-type="bibr" rid="b17">Daw <italic>et al.</italic>, 2000</xref>; <xref ref-type="bibr" rid="b21">Gardner <italic>et al.</italic>, 2005</xref>; <xref ref-type="bibr" rid="b37">Lin &#x00026; Huganir, 2007</xref>) and/or PICK1, a GluA2-linked trafficking protein (<xref ref-type="bibr" rid="b69">Staudinger <italic>et al.</italic>, 1995</xref>, <xref ref-type="bibr" rid="b70">1997</xref>; <xref ref-type="bibr" rid="b56">Perez <italic>et al.</italic>, 2001</xref>). Furthermore, the PKC isoform PKM&#x003b6; increases synaptic AMPAR and excitatory synaptic transmission (<xref ref-type="bibr" rid="b39">Ling <italic>et al.</italic>, 2006</xref>), probably by an NSF/GluA2-dependent mechanism that was recently found to maintain late-phase LTP through persistent trafficking of AMPAR to the synapse (<xref ref-type="bibr" rid="b77">Yao <italic>et al.</italic>, 2008</xref>). Thus, PKC-regulated synaptic trafficking of GluA2 might contribute to GluA1-independent LTP.</p><p>Finally, we showed that GluA1-independent LTP is attenuated by the nNOS inhibitors nNOSi I and V-LNIO. Because the exact intracellular concentrations of these drugs under our experimental conditions are unknown, we cannot rule out the possibility that the inhibitors also affected other NOS isoforms. Indeed, it was recently reported that endothelial NOS (eNOS) is also involved in a GluA1-independent form of LTP (<xref ref-type="bibr" rid="b57">Phillips <italic>et al.,</italic> 2008</xref>). In wild-type mice, nNOS is known to produce nitric oxide upon NMDAR activation (<xref ref-type="bibr" rid="b10">Bredt &#x00026; Snyder, 1989</xref>; <xref ref-type="bibr" rid="b22">Garthwaite <italic>et al.</italic>, 1989</xref>; <xref ref-type="bibr" rid="b12">Brenman <italic>et al.</italic>, 1996</xref>; <xref ref-type="bibr" rid="b11">Brenman &#x00026; Bredt, 1997</xref>), and nitric oxide can S-nitrosylate NSF (<xref ref-type="bibr" rid="b29">Huang <italic>et al.</italic>, 2005</xref>), another protein implicated in GluA2 trafficking. S-nitrosylation of NSF results in an increased surface expression of GluA2-containing AMPAR in cultured cerebellar and hippocampal neurons (<xref ref-type="bibr" rid="b29">Huang <italic>et al.</italic>, 2005</xref>; <xref ref-type="bibr" rid="b67">Sossa <italic>et al.</italic>, 2006</xref>, <xref ref-type="bibr" rid="b68">2007</xref>). Indeed, <xref ref-type="bibr" rid="b32">Kakegawa &#x00026; Yuzaki (2005)</xref> showed that such a mechanism could underlie GluA1-independent LTP at cerebellar parallel fibre&#x02013;Purkinje cell synapses. Although nNOS inhibitor I in our hands did not affect LTP in wild-type mice, a previous study reported that nNOS inhibitors produce a major loss of particularly the later phases of LTP (<xref ref-type="bibr" rid="b27">Hopper &#x00026; Garthwaite, 2006</xref>). Taken together with the evidence that GluA1-independent LTP might also require PKM&#x003b6;, it is possible that GluA1-independent mechanisms mediate or maintain later phases of LTP in wild-type mice.</p></sec><sec><title>Reduced synaptic transmission in Gria1<sup>&#x02212;/&#x02212;</sup> mice</title><p>Field excitatory synaptic transmission in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice was reduced relative to wild-type mice. Given the evidence that AMPAR in CA1 pyramidal neurons of wild-type mice mainly consist of GluA1/GluA2 heteromers, fewer GluA2/GluA3 complexes and some GluA1 homomers (<xref ref-type="bibr" rid="b76">Wenthold <italic>et al.</italic>, 1996</xref>), the observed reduction in excitatory synaptic transmission in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice is not surprising. On the other hand, the majority of AMPAR in CA1 pyramidal neurons are found at extrasynaptic sites (<xref ref-type="bibr" rid="b64">Shi <italic>et al.</italic>, 1999</xref>), so GluA1-lacking AMPAR might be able to compensate for the missing GluA1-containing AMPAR at the synapse. Indeed, <xref ref-type="bibr" rid="b78">Zamanillo <italic>et al.</italic> (1999)</xref> reported that AMPAR currents in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice are strongly reduced at the soma, but largely unaltered at synaptic sites on the proximal dendrites, which seems to be at odds with our findings. While we cannot explain this apparent discrepancy, a more recent study showed that AMPAR-mediated currents at more distal dendritic sites in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice are prominently reduced (<xref ref-type="bibr" rid="b1">Andrasfalvy <italic>et al.</italic>, 2003</xref>), and <xref ref-type="bibr" rid="b30">Jensen <italic>et al.</italic> (2003)</xref> reported a strongly reduced synaptic AMPA/NMDA current ratio in adult (&#x0003e;P42) <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice.</p></sec><sec><title>Does GluA1-independent LTP exist in wild-type mice?</title><p>A common problem of working with genetically modified mice is that deletion of a gene might alter developmental processes. Cellular, transcriptional and/or nuclear plasticity might compensate for the lack of a gene by recruiting mechanisms/proteins/genes not normally used for a function, or by developing entirely new mechanisms. Thus, the GluA1-independent, GluN2B-, nNOS- and PKC-dependent form of LTP that we describe in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice might be the result of altered development or the recruitment of GluA1-independent mechanisms not present in wild-type mice. However, similar cellular signalling cascades involving nitric oxide and PKC have previously been shown to mediate AMPAR exocytosis in cultured hippocampal neurons (<xref ref-type="bibr" rid="b68">Sossa <italic>et al.</italic>, 2007</xref>) and mediate activity-regulated GluA2 surface expression in wild-type animals (<xref ref-type="bibr" rid="b17">Daw <italic>et al.</italic>, 2000</xref>; <xref ref-type="bibr" rid="b24">Hayashi <italic>et al.</italic>, 2000</xref>; <xref ref-type="bibr" rid="b55">Passafaro <italic>et al.</italic>, 2001</xref>; <xref ref-type="bibr" rid="b77">Yao <italic>et al.</italic>, 2008</xref>). Whether GluA1-dependent and GluA1-independent mechanisms in wild-type mice are really as separable as our data from <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice suggest remains to be investigated. Because most AMPAR at hippocampal synapses of wild-type mice consist of either GluA1/GluA2 or GluA2/GluA3 heteromers (<xref ref-type="bibr" rid="b76">Wenthold <italic>et al.</italic>, 1996</xref>), an interaction of both GluA1- and GluA2-linked (and possibly GluA3-linked) trafficking/anchoring cascades is likely to determine the synaptic expression and maintenance of these receptors, and therefore the ultimate magnitude and persistence of LTP. Hence, GluA1-independent LTP as uncovered in <italic>Gria1</italic><sup>&#x02212;/&#x02212;</sup> mice might be redundant for some but not all phases of LTP in wild-type mice, which would explain why the first hour of LTP in wild-type mice neither required GluN2B nor nNOS.</p><p>Interestingly, the dissociation of GluA1-dependent and GluA1-independent potentiation is matched by a dissociation of two types of hippocampus-dependent spatial memory: the GluA1 subunit is necessary for spatial working memory, whereas the gradual acquisition of spatial reference memory tasks is GluA1-independent (<xref ref-type="bibr" rid="b61">Reisel <italic>et al.</italic>, 2002</xref>; <xref ref-type="bibr" rid="b63">Schmitt <italic>et al.</italic>, 2003</xref>; <xref ref-type="bibr" rid="b62">Sanderson <italic>et al.</italic>, 2007</xref>). In neither case (plasticity or behaviour) is the short-term process required for the long-term process to manifest. This highlights the importance of distinguishing between different plasticity mechanisms when addressing the relationship between synaptic plasticity and memory.</p></sec></sec></body><back><ack><p>This work was supported by The Wellcome Trust (grant number 074385; D.M.B.), the Medical Research Council, UK (grant number G0400571; O.P.), the Deutsche Forschungsgemeinschaft (grant number SFB636/A4 and SP 602/2-1; R.S.) and the Volkswagen Foundation (R.S.). C.R. was supported by a Wellcome Trust 4-year studentship. We thank Dr Y. Auberson, Novartis AG, for supplying NVP-AAM077.</p></ack><glossary><def-list><title>Abbreviations</title><def-item><term>aCSF</term><def><p>artificial cerebrospinal fluid</p></def></def-item><def-item><term>AMPA</term><def><p>&#x003b1;-amino-3-hydroxy-5-methyl-4-isoxazole proprionic acid</p></def></def-item><def-item><term>AMPAR</term><def><p>AMPA-type glutamate receptor(s)</p></def></def-item><def-item><term>CaMKII</term><def><p>Ca<sup>2+</sup>/calmodulin-dependent protein kinase II</p></def></def-item><def-item><term>CPP</term><def><p>3-(R-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid</p></def></def-item><def-item><term>EPSP</term><def><p>excitatory postsynaptic potential</p></def></def-item><def-item><term>fEPSP</term><def><p>field excitatory postsynaptic potential</p></def></def-item><def-item><term>KN-62</term><def><p>4-[(2<italic>S</italic>)-2-[(5-isoquinolinylsulphonyl)methylamino]-3-oxo-3-(4-phenyl-1-piperazinyl)propyl] phenylisoquinolinesulphonic acid ester</p></def></def-item><def-item><term>LTP</term><def><p>long-term potentiation</p></def></def-item><def-item><term>NMDA</term><def><p><italic>N</italic>-methyl-<sc>d</sc>-aspartate</p></def></def-item><def-item><term>NMDAR</term><def><p>NMDA-type glutamate receptor(s)</p></def></def-item><def-item><term>nNOS</term><def><p>neuronal nitric oxide synthase</p></def></def-item><def-item><term>NSF</term><def><p><italic>N</italic>-ethylmaleimide-sensitive factor</p></def></def-item><def-item><term>NVP-AAM077</term><def><p>(<italic>R</italic>)-[(<italic>S</italic>)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl-phosphonic acid</p></def></def-item><def-item><term>PICK1</term><def><p>protein interacting with C kinase-1</p></def></def-item><def-item><term>PKC</term><def><p>protein kinase C</p></def></def-item><def-item><term>PKM&#x003b6;</term><def><p>protein kinase M&#x003b6;</p></def></def-item><def-item><term>PPR</term><def><p>paired-pulse ratio</p></def></def-item><def-item><term>pTBS</term><def><p>paired synaptic-antidromic theta-burst stimulation</p></def></def-item><def-item><term>RM</term><def><p>repeated-measures</p></def></def-item><def-item><term>Ro 25-6981</term><def><p>(<italic>&#x003b1;R,&#x003b2;S</italic>)-&#x003b1;-(5-hydroxyphenyl)-&#x003b2;-methyl-4-(phenylmethyl)-1-piperidinepropanol</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="b1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andrasfalvy</surname><given-names>BK</given-names></name><name><surname>Smith</surname><given-names>MA</given-names></name><name><surname>Borchardt</surname><given-names>T</given-names></name><name><surname>Sprengel</surname><given-names>R</given-names></name><name><surname>Magee</surname><given-names>JC</given-names></name></person-group><article-title>Impaired regulation of synaptic strength in hippocampal neurons from GluR1-deficient mice</article-title><source>J. Physiol.</source><year>2003</year><volume>552</volume><fpage>35</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">12878757</pub-id></citation></ref><ref id="b2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Auberson</surname><given-names>YP</given-names></name><name><surname>Allgeier</surname><given-names>H</given-names></name><name><surname>Bischoff</surname><given-names>S</given-names></name><name><surname>Lingenhoehl</surname><given-names>K</given-names></name><name><surname>Moretti</surname><given-names>R</given-names></name><name><surname>Schmutz</surname><given-names>M</given-names></name></person-group><article-title>5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2002</year><volume>12</volume><fpage>1099</fpage><lpage>1102</lpage><pub-id pub-id-type="pmid">11909726</pub-id></citation></ref><ref id="b3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barria</surname><given-names>A</given-names></name><name><surname>Malinow</surname><given-names>R</given-names></name></person-group><article-title>NMDA receptor subunit composition controls synaptic plasticity by regulating binding to CaMKII</article-title><source>Neuron</source><year>2005</year><volume>48</volume><fpage>289</fpage><lpage>301</lpage><pub-id pub-id-type="pmid">16242409</pub-id></citation></ref><ref id="b4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barria</surname><given-names>A</given-names></name><name><surname>Muller</surname><given-names>D</given-names></name><name><surname>Derkach</surname><given-names>V</given-names></name><name><surname>Griffith</surname><given-names>LC</given-names></name><name><surname>Soderling</surname><given-names>TR</given-names></name></person-group><article-title>Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-KII during long-term potentiation</article-title><source>Science</source><year>1997</year><volume>276</volume><fpage>2042</fpage><lpage>2045</lpage><pub-id pub-id-type="pmid">9197267</pub-id></citation></ref><ref id="b5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Benke</surname><given-names>TA</given-names></name><name><surname>Luthi</surname><given-names>A</given-names></name><name><surname>Isaac</surname><given-names>JT</given-names></name><name><surname>Collingridge</surname><given-names>GL</given-names></name></person-group><article-title>Modulation of AMPA receptor unitary conductance by synaptic activity</article-title><source>Nature</source><year>1998</year><volume>393</volume><fpage>793</fpage><lpage>797</lpage><pub-id pub-id-type="pmid">9655394</pub-id></citation></ref><ref id="b6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berberich</surname><given-names>S</given-names></name><name><surname>Punnakkal</surname><given-names>P</given-names></name><name><surname>Jensen</surname><given-names>V</given-names></name><name><surname>Pawlak</surname><given-names>V</given-names></name><name><surname>Seeburg</surname><given-names>PH</given-names></name><name><surname>Hvalby</surname><given-names>O</given-names></name><name><surname>Kohr</surname><given-names>G</given-names></name></person-group><article-title>Lack of NMDA receptor subtype selectivity for hippocampal long-term potentiation</article-title><source>J. Neurosci.</source><year>2005</year><volume>25</volume><fpage>6907</fpage><lpage>6910</lpage><pub-id pub-id-type="pmid">16033900</pub-id></citation></ref><ref id="b7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bliss</surname><given-names>TV</given-names></name><name><surname>Collingridge</surname><given-names>GL</given-names></name></person-group><article-title>A synaptic model of memory: long-term potentiation in the hippocampus</article-title><source>Nature</source><year>1993</year><volume>361</volume><fpage>31</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">8421494</pub-id></citation></ref><ref id="b8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bliss</surname><given-names>TVP</given-names></name><name><surname>L&#x000f8;mo</surname><given-names>T</given-names></name></person-group><article-title>Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path</article-title><source>J. Physiol.</source><year>1973</year><volume>232</volume><fpage>331</fpage><lpage>356</lpage><pub-id pub-id-type="pmid">4727084</pub-id></citation></ref><ref id="b9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boehm</surname><given-names>J</given-names></name><name><surname>Kang</surname><given-names>MG</given-names></name><name><surname>Johnson</surname><given-names>RC</given-names></name><name><surname>Esteban</surname><given-names>J</given-names></name><name><surname>Huganir</surname><given-names>RL</given-names></name><name><surname>Malinow</surname><given-names>R</given-names></name></person-group><article-title>Synaptic incorporation of AMPA receptors during LTP is controlled by a PKC phosphorylation site on GluR1</article-title><source>Neuron</source><year>2006</year><volume>51</volume><fpage>213</fpage><lpage>225</lpage><pub-id pub-id-type="pmid">16846856</pub-id></citation></ref><ref id="b10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bredt</surname><given-names>DS</given-names></name><name><surname>Snyder</surname><given-names>SH</given-names></name></person-group><article-title>Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum</article-title><source>Proc. Natl Acad. Sci. USA</source><year>1989</year><volume>86</volume><fpage>9030</fpage><lpage>9033</lpage><pub-id pub-id-type="pmid">2573074</pub-id></citation></ref><ref id="b11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brenman</surname><given-names>JE</given-names></name><name><surname>Bredt</surname><given-names>DS</given-names></name></person-group><article-title>Synaptic signaling by nitric oxide</article-title><source>Curr. Opin. Neurobiol.</source><year>1997</year><volume>7</volume><fpage>374</fpage><lpage>378</lpage><pub-id pub-id-type="pmid">9232800</pub-id></citation></ref><ref id="b12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brenman</surname><given-names>JE</given-names></name><name><surname>Chao</surname><given-names>DS</given-names></name><name><surname>Gee</surname><given-names>SH</given-names></name><name><surname>McGee</surname><given-names>AW</given-names></name><name><surname>Craven</surname><given-names>SE</given-names></name><name><surname>Santillano</surname><given-names>DR</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Huang</surname><given-names>F</given-names></name><name><surname>Xia</surname><given-names>H</given-names></name><name><surname>Peters</surname><given-names>MF</given-names></name><name><surname>Froehner</surname><given-names>SC</given-names></name><name><surname>Bredt</surname><given-names>DS</given-names></name></person-group><article-title>Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains</article-title><source>Cell</source><year>1996</year><volume>84</volume><fpage>757</fpage><lpage>767</lpage><pub-id pub-id-type="pmid">8625413</pub-id></citation></ref><ref id="b13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Casta&#x000f1;eda-Castellanos</surname><given-names>DR</given-names></name><name><surname>Flint</surname><given-names>AC</given-names></name><name><surname>Kriegstein</surname><given-names>AR</given-names></name></person-group><article-title>Blind patch clamp recordings in embryonic and adult mammalian brain slices</article-title><source>Nat. Protoc.</source><year>2006</year><volume>1</volume><fpage>532</fpage><lpage>542</lpage><pub-id pub-id-type="pmid">17406279</pub-id></citation></ref><ref id="b14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Collingridge</surname><given-names>GL</given-names></name><name><surname>Randall</surname><given-names>AD</given-names></name><name><surname>Davies</surname><given-names>CH</given-names></name><name><surname>Alford</surname><given-names>S</given-names></name></person-group><article-title>The synaptic activation of NMDA receptors and Ca<sup>2+</sup> signalling in neurons</article-title><source>Ciba Found. Symp.</source><year>1992</year><volume>164</volume><fpage>162</fpage><lpage>171</lpage><comment>discussion 172&#x02013;165</comment><pub-id pub-id-type="pmid">1327677</pub-id></citation></ref><ref id="b15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Collingridge</surname><given-names>GL</given-names></name><name><surname>Olsen</surname><given-names>RW</given-names></name><name><surname>Peters</surname><given-names>J</given-names></name><name><surname>Spedding</surname><given-names>M</given-names></name></person-group><article-title>A nomenclature for ligand-gated ion channels</article-title><source>Neuropharmacology</source><year>2009</year><volume>56</volume><fpage>2</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">18655795</pub-id></citation></ref><ref id="b16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cull-Candy</surname><given-names>S</given-names></name><name><surname>Brickley</surname><given-names>S</given-names></name><name><surname>Farrant</surname><given-names>M</given-names></name></person-group><article-title>NMDA receptor subunits: diversity, development and disease</article-title><source>Curr. Opin. Neurobiol.</source><year>2001</year><volume>11</volume><fpage>327</fpage><lpage>335</lpage><pub-id pub-id-type="pmid">11399431</pub-id></citation></ref><ref id="b17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Daw</surname><given-names>MI</given-names></name><name><surname>Chittajallu</surname><given-names>R</given-names></name><name><surname>Bortolotto</surname><given-names>ZA</given-names></name><name><surname>Dev</surname><given-names>KK</given-names></name><name><surname>Duprat</surname><given-names>F</given-names></name><name><surname>Henley</surname><given-names>JM</given-names></name><name><surname>Collingridge</surname><given-names>GL</given-names></name><name><surname>Isaac</surname><given-names>JT</given-names></name></person-group><article-title>PDZ proteins interacting with C-terminal GluR2/3 are involved in a PKC-dependent regulation of AMPA receptors at hippocampal synapses</article-title><source>Neuron</source><year>2000</year><volume>28</volume><fpage>873</fpage><lpage>886</lpage><pub-id pub-id-type="pmid">11163273</pub-id></citation></ref><ref id="b18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Derkach</surname><given-names>V</given-names></name><name><surname>Barria</surname><given-names>A</given-names></name><name><surname>Soderling</surname><given-names>TR</given-names></name></person-group><article-title>Ca<sup>2+</sup>/calmodulin-kinase II enhances channel conductance of &#x003b1;-amino-3-hydroxy-5-methyl-4-isoxazolepropionate type glutamate receptors</article-title><source>Proc. Natl Acad. Sci. USA</source><year>1999</year><volume>96</volume><fpage>3269</fpage><lpage>3274</lpage><pub-id pub-id-type="pmid">10077673</pub-id></citation></ref><ref id="b19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Enslen</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>P</given-names></name><name><surname>Brickey</surname><given-names>D</given-names></name><name><surname>Soderling</surname><given-names>S</given-names></name><name><surname>Klamo</surname><given-names>E</given-names></name><name><surname>Soderling</surname><given-names>TR</given-names></name></person-group><article-title>Characterization of Ca<sup>2+</sup>/calmodulin-dependent kinase IV. Role in transcriptional regulation</article-title><source>J. Biol. Chem.</source><year>1994</year><volume>269</volume><fpage>15520</fpage><lpage>15527</lpage><pub-id pub-id-type="pmid">8195196</pub-id></citation></ref><ref id="b20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>G</given-names></name><name><surname>Mutel</surname><given-names>V</given-names></name><name><surname>Trube</surname><given-names>G</given-names></name><name><surname>Malherbe</surname><given-names>P</given-names></name><name><surname>Kew</surname><given-names>JN</given-names></name><name><surname>Mohacsi</surname><given-names>E</given-names></name><name><surname>Heitz</surname><given-names>MP</given-names></name><name><surname>Kemp</surname><given-names>JA</given-names></name></person-group><article-title>Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro</article-title><source>J. Pharmacol. Exp. Ther.</source><year>1997</year><volume>283</volume><fpage>1285</fpage><lpage>1292</lpage><pub-id pub-id-type="pmid">9400004</pub-id></citation></ref><ref id="b21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gardner</surname><given-names>SM</given-names></name><name><surname>Takamiya</surname><given-names>K</given-names></name><name><surname>Xia</surname><given-names>J</given-names></name><name><surname>Suh</surname><given-names>JG</given-names></name><name><surname>Johnson</surname><given-names>R</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Huganir</surname><given-names>RL</given-names></name></person-group><article-title>Calcium-permeable AMPA receptor plasticity is mediated by subunit-specific interactions with PICK1 and NSF</article-title><source>Neuron</source><year>2005</year><volume>45</volume><fpage>903</fpage><lpage>915</lpage><pub-id pub-id-type="pmid">15797551</pub-id></citation></ref><ref id="b22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garthwaite</surname><given-names>J</given-names></name><name><surname>Garthwaite</surname><given-names>G</given-names></name><name><surname>Palmer</surname><given-names>RM</given-names></name><name><surname>Moncada</surname><given-names>S</given-names></name></person-group><article-title>NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices</article-title><source>Eur. J. Pharmacol.</source><year>1989</year><volume>172</volume><fpage>413</fpage><lpage>416</lpage><pub-id pub-id-type="pmid">2555211</pub-id></citation></ref><ref id="b23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hah</surname><given-names>JM</given-names></name><name><surname>Roman</surname><given-names>LJ</given-names></name><name><surname>Martasek</surname><given-names>P</given-names></name><name><surname>Silverman</surname><given-names>RB</given-names></name></person-group><article-title>Reduced amide bond peptidomimetics. (4S)-N-(4-amino-5-[aminoakyl]aminopentyl)-N&#x02032;-nitroguanidines, potent and highly selective inhibitors of neuronal nitric oxide synthase</article-title><source>J. Med. Chem.</source><year>2001</year><volume>44</volume><fpage>2667</fpage><lpage>2670</lpage><pub-id pub-id-type="pmid">11472219</pub-id></citation></ref><ref id="b24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>SH</given-names></name><name><surname>Esteban</surname><given-names>JA</given-names></name><name><surname>Piccini</surname><given-names>A</given-names></name><name><surname>Poncer</surname><given-names>JC</given-names></name><name><surname>Malinow</surname><given-names>R</given-names></name></person-group><article-title>Driving AMPA receptors into synapses by LTP and CaMKII: requirement for GluR1 and PDZ domain interaction</article-title><source>Science</source><year>2000</year><volume>287</volume><fpage>2262</fpage><lpage>2267</lpage><pub-id pub-id-type="pmid">10731148</pub-id></citation></ref><ref id="b25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Herbert</surname><given-names>JM</given-names></name><name><surname>Augereau</surname><given-names>JM</given-names></name><name><surname>Gleye</surname><given-names>J</given-names></name><name><surname>Maffrand</surname><given-names>JP</given-names></name></person-group><article-title>Chelerythrine is a potent and specific inhibitor of protein kinase C</article-title><source>Biochem. Biophys. Res. Commun.</source><year>1990</year><volume>172</volume><fpage>993</fpage><lpage>999</lpage><pub-id pub-id-type="pmid">2244923</pub-id></citation></ref><ref id="b26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hoffman</surname><given-names>DA</given-names></name><name><surname>Sprengel</surname><given-names>R</given-names></name><name><surname>Sakmann</surname><given-names>B</given-names></name></person-group><article-title>Molecular dissection of hippocampal theta-burst pairing potentiation</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2002</year><volume>99</volume><fpage>7740</fpage><lpage>7745</lpage><pub-id pub-id-type="pmid">12032353</pub-id></citation></ref><ref id="b27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hopper</surname><given-names>RA</given-names></name><name><surname>Garthwaite</surname><given-names>J</given-names></name></person-group><article-title>Tonic and phasic nitric oxide signals in hippocampal long-term potentiation</article-title><source>J. Neurosci.</source><year>2006</year><volume>26</volume><fpage>11513</fpage><lpage>11521</lpage><pub-id pub-id-type="pmid">17093072</pub-id></citation></ref><ref id="b28"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Howell</surname><given-names>DC</given-names></name></person-group><source>Statistical Methods for Psychology</source><year>1997</year><publisher-loc>Belmont</publisher-loc><publisher-name>Duxbury</publisher-name></citation></ref><ref id="b29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Man</surname><given-names>HY</given-names></name><name><surname>Sekine-Aizawa</surname><given-names>Y</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>Juluri</surname><given-names>K</given-names></name><name><surname>Luo</surname><given-names>H</given-names></name><name><surname>Cheah</surname><given-names>J</given-names></name><name><surname>Lowenstein</surname><given-names>C</given-names></name><name><surname>Huganir</surname><given-names>RL</given-names></name><name><surname>Snyder</surname><given-names>SH</given-names></name></person-group><article-title>S-nitrosylation of N-ethylmaleimide sensitive factor mediates surface expression of AMPA receptors</article-title><source>Neuron</source><year>2005</year><volume>46</volume><fpage>533</fpage><lpage>540</lpage><pub-id pub-id-type="pmid">15944123</pub-id></citation></ref><ref id="b30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>V</given-names></name><name><surname>Kaiser</surname><given-names>KM</given-names></name><name><surname>Borchardt</surname><given-names>T</given-names></name><name><surname>Adelmann</surname><given-names>G</given-names></name><name><surname>Rozov</surname><given-names>A</given-names></name><name><surname>Burnashev</surname><given-names>N</given-names></name><name><surname>Brix</surname><given-names>C</given-names></name><name><surname>Frotscher</surname><given-names>M</given-names></name><name><surname>Andersen</surname><given-names>P</given-names></name><name><surname>Hvalby</surname><given-names>O</given-names></name><name><surname>Sakmann</surname><given-names>B</given-names></name><name><surname>Seeburg</surname><given-names>PH</given-names></name><name><surname>Sprengel</surname><given-names>R</given-names></name></person-group><article-title>A juvenile form of postsynaptic hippocampal long-term potentiation in mice deficient for the AMPA receptor subunit GluR-A</article-title><source>J. Physiol.</source><year>2003</year><volume>553</volume><fpage>843</fpage><lpage>856</lpage><pub-id pub-id-type="pmid">14555717</pub-id></citation></ref><ref id="b31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>S-C</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Hoffman</surname><given-names>DA</given-names></name></person-group><article-title>Rapid, bidirectional remodeling of synaptic NMDA receptor subunit composition by A-type K<sup>+</sup> channel activity in hippocampal CA1 pyramidal neurons</article-title><source>Neuron</source><year>2008</year><volume>60</volume><fpage>657</fpage><lpage>671</lpage><pub-id pub-id-type="pmid">19038222</pub-id></citation></ref><ref id="b32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kakegawa</surname><given-names>W</given-names></name><name><surname>Yuzaki</surname><given-names>M</given-names></name></person-group><article-title>A mechanism underlying AMPA receptor trafficking during cerebellar long-term potentiation</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2005</year><volume>102</volume><fpage>17846</fpage><lpage>17851</lpage><pub-id pub-id-type="pmid">16303868</pub-id></citation></ref><ref id="b33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>MJ</given-names></name><name><surname>Dunah</surname><given-names>AW</given-names></name><name><surname>Wang</surname><given-names>YT</given-names></name><name><surname>Sheng</surname><given-names>M</given-names></name></person-group><article-title>Differential roles of NR2A- and NR2B-containing NMDA receptors in Ras-ERK signaling and AMPA receptor trafficking</article-title><source>Neuron</source><year>2005</year><volume>46</volume><fpage>745</fpage><lpage>760</lpage><pub-id pub-id-type="pmid">15924861</pub-id></citation></ref><ref id="b34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>K&#x000f6;hr</surname><given-names>G</given-names></name></person-group><article-title>NMDA receptor function: subunit composition versus spatial distribution</article-title><source>Cell Tissue Res.</source><year>2006</year><volume>326</volume><fpage>439</fpage><lpage>446</lpage><pub-id pub-id-type="pmid">16862427</pub-id></citation></ref><ref id="b35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>HK</given-names></name><name><surname>Barbarosie</surname><given-names>M</given-names></name><name><surname>Kameyama</surname><given-names>K</given-names></name><name><surname>Bear</surname><given-names>MF</given-names></name><name><surname>Huganir</surname><given-names>RL</given-names></name></person-group><article-title>Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity</article-title><source>Nature</source><year>2000</year><volume>405</volume><fpage>955</fpage><lpage>959</lpage><pub-id pub-id-type="pmid">10879537</pub-id></citation></ref><ref id="b36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>HK</given-names></name><name><surname>Takamiya</surname><given-names>K</given-names></name><name><surname>Han</surname><given-names>JS</given-names></name><name><surname>Man</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>CH</given-names></name><name><surname>Rumbaugh</surname><given-names>G</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Ding</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>C</given-names></name><name><surname>Petralia</surname><given-names>RS</given-names></name><name><surname>Wenthold</surname><given-names>RJ</given-names></name><name><surname>Gallagher</surname><given-names>M</given-names></name><name><surname>Huganir</surname><given-names>RL</given-names></name></person-group><article-title>Phosphorylation of the AMPA receptor GluR1 subunit is required for synaptic plasticity and retention of spatial memory</article-title><source>Cell</source><year>2003</year><volume>112</volume><fpage>631</fpage><lpage>643</lpage><pub-id pub-id-type="pmid">12628184</pub-id></citation></ref><ref id="b37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>DT</given-names></name><name><surname>Huganir</surname><given-names>RL</given-names></name></person-group><article-title>PICK1 and phosphorylation of the glutamate receptor 2 (GluR2) AMPA receptor subunit regulates GluR2 recycling after NMDA receptor-induced internalization</article-title><source>J. Neurosci.</source><year>2007</year><volume>27</volume><fpage>13903</fpage><lpage>13908</lpage><pub-id pub-id-type="pmid">18077702</pub-id></citation></ref><ref id="b38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname><given-names>DS</given-names></name><name><surname>Benardo</surname><given-names>LS</given-names></name><name><surname>Serrano</surname><given-names>PA</given-names></name><name><surname>Blace</surname><given-names>N</given-names></name><name><surname>Kelly</surname><given-names>MT</given-names></name><name><surname>Crary</surname><given-names>JF</given-names></name><name><surname>Sacktor</surname><given-names>TC</given-names></name></person-group><article-title>Protein kinase Mzeta is necessary and sufficient for LTP maintenance</article-title><source>Nat. Neurosci.</source><year>2002</year><volume>5</volume><fpage>295</fpage><lpage>296</lpage><pub-id pub-id-type="pmid">11914719</pub-id></citation></ref><ref id="b39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname><given-names>DS</given-names></name><name><surname>Benardo</surname><given-names>LS</given-names></name><name><surname>Sacktor</surname><given-names>TC</given-names></name></person-group><article-title>Protein kinase Mzeta enhances excitatory synaptic transmission by increasing the number of active postsynaptic AMPA receptors</article-title><source>Hippocampus</source><year>2006</year><volume>16</volume><fpage>443</fpage><lpage>452</lpage><pub-id pub-id-type="pmid">16463388</pub-id></citation></ref><ref id="b40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lisman</surname><given-names>J</given-names></name><name><surname>Schulman</surname><given-names>H</given-names></name><name><surname>Cline</surname><given-names>H</given-names></name></person-group><article-title>The molecular basis of CaMKII function in synaptic and behavioural memory</article-title><source>Nat. Rev. Neurosci.</source><year>2002</year><volume>3</volume><fpage>175</fpage><lpage>190</lpage><pub-id pub-id-type="pmid">11994750</pub-id></citation></ref><ref id="b41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Wong</surname><given-names>TP</given-names></name><name><surname>Pozza</surname><given-names>MF</given-names></name><name><surname>Lingenhoehl</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Sheng</surname><given-names>M</given-names></name><name><surname>Auberson</surname><given-names>YP</given-names></name><name><surname>Wang</surname><given-names>YT</given-names></name></person-group><article-title>Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity</article-title><source>Science</source><year>2004</year><volume>304</volume><fpage>1021</fpage><lpage>1024</lpage><pub-id pub-id-type="pmid">15143284</pub-id></citation></ref><ref id="b42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Man</surname><given-names>H</given-names></name><name><surname>Ju</surname><given-names>W</given-names></name><name><surname>Trimble</surname><given-names>WS</given-names></name><name><surname>MacDonald</surname><given-names>JF</given-names></name><name><surname>Wang</surname><given-names>YT</given-names></name></person-group><article-title>Activation of synaptic NMDA receptors induces membrane insertion of new AMPA receptors and LTP in cultured hippocampal neurons</article-title><source>Neuron</source><year>2001</year><volume>29</volume><fpage>243</fpage><lpage>254</lpage><pub-id pub-id-type="pmid">11182095</pub-id></citation></ref><ref id="b43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lynch</surname><given-names>G</given-names></name><name><surname>Larson</surname><given-names>J</given-names></name><name><surname>Kelso</surname><given-names>S</given-names></name><name><surname>Barrionuevo</surname><given-names>G</given-names></name><name><surname>Schottler</surname><given-names>F</given-names></name></person-group><article-title>Intracellular injections of EGTA block induction of hippocampal long-term potentiation</article-title><source>Nature</source><year>1983</year><volume>305</volume><fpage>719</fpage><lpage>721</lpage><pub-id pub-id-type="pmid">6415483</pub-id></citation></ref><ref id="b44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malenka</surname><given-names>RC</given-names></name><name><surname>Bear</surname><given-names>MF</given-names></name></person-group><article-title>LTP and LTD: an embarrassment of riches</article-title><source>Neuron</source><year>2004</year><volume>44</volume><fpage>5</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">15450156</pub-id></citation></ref><ref id="b45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malinow</surname><given-names>R</given-names></name><name><surname>Madison</surname><given-names>DV</given-names></name><name><surname>Tsien</surname><given-names>RW</given-names></name></person-group><article-title>Persistent protein kinase activity underlying long-term potentiation</article-title><source>Nature</source><year>1988</year><volume>335</volume><fpage>820</fpage><lpage>824</lpage><pub-id pub-id-type="pmid">2847049</pub-id></citation></ref><ref id="b46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malinow</surname><given-names>R</given-names></name><name><surname>Schulman</surname><given-names>H</given-names></name><name><surname>Tsien</surname><given-names>RW</given-names></name></person-group><article-title>Inhibition of postsynaptic PKC or CaMKII blocks induction but not expression of LTP</article-title><source>Science</source><year>1989</year><volume>245</volume><fpage>862</fpage><lpage>866</lpage><pub-id pub-id-type="pmid">2549638</pub-id></citation></ref><ref id="b47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>SJ</given-names></name><name><surname>Morris</surname><given-names>RG</given-names></name></person-group><article-title>New life in an old idea: the synaptic plasticity and memory hypothesis revisited</article-title><source>Hippocampus</source><year>2002</year><volume>12</volume><fpage>609</fpage><lpage>636</lpage><pub-id pub-id-type="pmid">12440577</pub-id></citation></ref><ref id="b48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>SJ</given-names></name><name><surname>Grimwood</surname><given-names>PD</given-names></name><name><surname>Morris</surname><given-names>RG</given-names></name></person-group><article-title>Synaptic plasticity and memory: an evaluation of the hypothesis</article-title><source>Annu. Rev. Neurosci.</source><year>2000</year><volume>23</volume><fpage>649</fpage><lpage>711</lpage><pub-id pub-id-type="pmid">10845078</pub-id></citation></ref><ref id="b49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McNaughton</surname><given-names>BL</given-names></name></person-group><article-title>Long-term synaptic enhancement and short-term potentiation in rat fascia dentata act through different mechanisms</article-title><source>J. Physiol.</source><year>1982</year><volume>324</volume><fpage>249</fpage><lpage>262</lpage><pub-id pub-id-type="pmid">7097600</pub-id></citation></ref><ref id="b50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Monyer</surname><given-names>H</given-names></name><name><surname>Burnashev</surname><given-names>N</given-names></name><name><surname>Laurie</surname><given-names>DJ</given-names></name><name><surname>Sakmann</surname><given-names>B</given-names></name><name><surname>Seeburg</surname><given-names>PH</given-names></name></person-group><article-title>Developmental and regional expression in the rat brain and functional properties of four NMDA receptors</article-title><source>Neuron</source><year>1994</year><volume>12</volume><fpage>529</fpage><lpage>540</lpage><pub-id pub-id-type="pmid">7512349</pub-id></citation></ref><ref id="b51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neyton</surname><given-names>J</given-names></name><name><surname>Paoletti</surname><given-names>P</given-names></name></person-group><article-title>Relating NMDA receptor function to receptor subunit composition: limitations of the pharmacological approach</article-title><source>J. Neurosci.</source><year>2006</year><volume>26</volume><fpage>1331</fpage><lpage>1333</lpage><pub-id pub-id-type="pmid">16452656</pub-id></citation></ref><ref id="b52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>MC</given-names></name><name><surname>Derkach</surname><given-names>VA</given-names></name></person-group><article-title>Dominant role of the GluR2 subunit in regulation of AMPA receptors by CaMKII</article-title><source>Nat. Neurosci.</source><year>2005</year><volume>8</volume><fpage>853</fpage><lpage>854</lpage><pub-id pub-id-type="pmid">15924137</pub-id></citation></ref><ref id="b53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>MC</given-names></name><name><surname>Derkach</surname><given-names>VA</given-names></name><name><surname>Guire</surname><given-names>ES</given-names></name><name><surname>Soderling</surname><given-names>TR</given-names></name></person-group><article-title>Extrasynaptic membrane trafficking regulated by GluR1 serine 845 phosphorylation primes AMPA receptors for long-term potentiation</article-title><source>J. Biol. Chem.</source><year>2006</year><volume>281</volume><fpage>752</fpage><lpage>758</lpage><pub-id pub-id-type="pmid">16272153</pub-id></citation></ref><ref id="b54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oren</surname><given-names>I</given-names></name><name><surname>Mann</surname><given-names>EO</given-names></name><name><surname>Paulsen</surname><given-names>O</given-names></name><name><surname>Hajos</surname><given-names>N</given-names></name></person-group><article-title>Synaptic currents in anatomically identified CA3 neurons during hippocampal gamma oscillations in vitro</article-title><source>J. Neurosci.</source><year>2006</year><volume>26</volume><fpage>9923</fpage><lpage>9934</lpage><pub-id pub-id-type="pmid">17005856</pub-id></citation></ref><ref id="b55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Passafaro</surname><given-names>M</given-names></name><name><surname>Piech</surname><given-names>V</given-names></name><name><surname>Sheng</surname><given-names>M</given-names></name></person-group><article-title>Subunit-specific temporal and spatial patterns of AMPA receptor exocytosis in hippocampal neurons</article-title><source>Nat. Neurosci.</source><year>2001</year><volume>4</volume><fpage>917</fpage><lpage>926</lpage><pub-id pub-id-type="pmid">11528423</pub-id></citation></ref><ref id="b56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perez</surname><given-names>JL</given-names></name><name><surname>Khatri</surname><given-names>L</given-names></name><name><surname>Chang</surname><given-names>C</given-names></name><name><surname>Srivastava</surname><given-names>S</given-names></name><name><surname>Osten</surname><given-names>P</given-names></name><name><surname>Ziff</surname><given-names>EB</given-names></name></person-group><article-title>PICK1 targets activated protein kinase Calpha to AMPA receptor clusters in spines of hippocampal neurons and reduces surface levels of the AMPA-type glutamate receptor subunit 2</article-title><source>J. Neurosci.</source><year>2001</year><volume>21</volume><fpage>5417</fpage><lpage>5428</lpage><pub-id pub-id-type="pmid">11466413</pub-id></citation></ref><ref id="b57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>KG</given-names></name><name><surname>Hardingham</surname><given-names>NR</given-names></name><name><surname>Fox</surname><given-names>K</given-names></name></person-group><article-title>Postsynaptic action potentials are required for nitric-oxide-dependent long-term potentiation in CA1 neurons of adult GluR1 knock-out wild-type mice</article-title><source>J. Neurosci.</source><year>2008</year><volume>28</volume><fpage>14031</fpage><lpage>14041</lpage><pub-id pub-id-type="pmid">19109486</pub-id></citation></ref><ref id="b58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Piccini</surname><given-names>A</given-names></name><name><surname>Malinow</surname><given-names>R</given-names></name></person-group><article-title>Critical postsynaptic density 95/disc large/zonula occludens-1 interactions by glutamate receptor 1 (GluR1) and GluR2 required at different subcellular sites</article-title><source>J. Neurosci.</source><year>2002</year><volume>22</volume><fpage>5387</fpage><lpage>5392</lpage><pub-id pub-id-type="pmid">12097490</pub-id></citation></ref><ref id="b59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raymond</surname><given-names>CR</given-names></name></person-group><article-title>LTP forms 1, 2 and 3: different mechanisms for the &#x0201c;long&#x0201d; in long-term potentiation</article-title><source>Trends Neurosci.</source><year>2007</year><volume>30</volume><fpage>167</fpage><lpage>175</lpage><pub-id pub-id-type="pmid">17292975</pub-id></citation></ref><ref id="b60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raymond</surname><given-names>CR</given-names></name><name><surname>Redman</surname><given-names>SJ</given-names></name></person-group><article-title>Different calcium sources are narrowly tuned to the induction of different forms of LTP</article-title><source>J. Neurophysiol.</source><year>2002</year><volume>88</volume><fpage>249</fpage><lpage>255</lpage><pub-id pub-id-type="pmid">12091550</pub-id></citation></ref><ref id="b61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reisel</surname><given-names>D</given-names></name><name><surname>Bannerman</surname><given-names>DM</given-names></name><name><surname>Schmitt</surname><given-names>WB</given-names></name><name><surname>Deacon</surname><given-names>RM</given-names></name><name><surname>Flint</surname><given-names>J</given-names></name><name><surname>Borchardt</surname><given-names>T</given-names></name><name><surname>Seeburg</surname><given-names>PH</given-names></name><name><surname>Rawlins</surname><given-names>JN</given-names></name></person-group><article-title>Spatial memory dissociations in mice lacking GluR1</article-title><source>Nat. Neurosci.</source><year>2002</year><volume>5</volume><fpage>868</fpage><lpage>873</lpage><pub-id pub-id-type="pmid">12195431</pub-id></citation></ref><ref id="b62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sanderson</surname><given-names>DJ</given-names></name><name><surname>Gray</surname><given-names>A</given-names></name><name><surname>Simon</surname><given-names>A</given-names></name><name><surname>Taylor</surname><given-names>AM</given-names></name><name><surname>Deacon</surname><given-names>RM</given-names></name><name><surname>Seeburg</surname><given-names>PH</given-names></name><name><surname>Sprengel</surname><given-names>R</given-names></name><name><surname>Good</surname><given-names>MA</given-names></name><name><surname>Rawlins</surname><given-names>JN</given-names></name><name><surname>Bannerman</surname><given-names>DM</given-names></name></person-group><article-title>Deletion of glutamate receptor-A (GluR-A) AMPA receptor subunits impairs one-trial spatial memory</article-title><source>Behav. Neurosci.</source><year>2007</year><volume>121</volume><fpage>559</fpage><lpage>569</lpage><pub-id pub-id-type="pmid">17592947</pub-id></citation></ref><ref id="b63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmitt</surname><given-names>WB</given-names></name><name><surname>Deacon</surname><given-names>RM</given-names></name><name><surname>Seeburg</surname><given-names>PH</given-names></name><name><surname>Rawlins</surname><given-names>JN</given-names></name><name><surname>Bannerman</surname><given-names>DM</given-names></name></person-group><article-title>A within-subjects, within-task demonstration of intact spatial reference memory and impaired spatial working memory in glutamate receptor-A-deficient mice</article-title><source>J. Neurosci.</source><year>2003</year><volume>23</volume><fpage>3953</fpage><lpage>3959</lpage><pub-id pub-id-type="pmid">12736365</pub-id></citation></ref><ref id="b64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>SH</given-names></name><name><surname>Hayashi</surname><given-names>Y</given-names></name><name><surname>Petralia</surname><given-names>RS</given-names></name><name><surname>Zaman</surname><given-names>SH</given-names></name><name><surname>Wenthold</surname><given-names>RJ</given-names></name><name><surname>Svoboda</surname><given-names>K</given-names></name><name><surname>Malinow</surname><given-names>R</given-names></name></person-group><article-title>Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation</article-title><source>Science</source><year>1999</year><volume>284</volume><fpage>1811</fpage><lpage>1816</lpage><pub-id pub-id-type="pmid">10364548</pub-id></citation></ref><ref id="b65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>S</given-names></name><name><surname>Hayashi</surname><given-names>Y</given-names></name><name><surname>Esteban</surname><given-names>JA</given-names></name><name><surname>Malinow</surname><given-names>R</given-names></name></person-group><article-title>Subunit-specific rules governing AMPA receptor trafficking to synapses in hippocampal pyramidal neurons</article-title><source>Cell</source><year>2001</year><volume>105</volume><fpage>331</fpage><lpage>343</lpage><pub-id pub-id-type="pmid">11348590</pub-id></citation></ref><ref id="b66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>J</given-names></name><name><surname>Stevens</surname><given-names>CF</given-names></name><name><surname>Tonegawa</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name></person-group><article-title>Deficient hippocampal long-term potentiation in alpha-calcium-calmodulin kinase II mutant mice</article-title><source>Science</source><year>1992</year><volume>257</volume><fpage>201</fpage><lpage>206</lpage><pub-id pub-id-type="pmid">1378648</pub-id></citation></ref><ref id="b67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sossa</surname><given-names>KG</given-names></name><name><surname>Court</surname><given-names>BL</given-names></name><name><surname>Carroll</surname><given-names>RC</given-names></name></person-group><article-title>NMDA receptors mediate calcium-dependent, bidirectional changes in dendritic PICK1 clustering</article-title><source>Mol. Cell. Neurosci.</source><year>2006</year><volume>31</volume><fpage>574</fpage><lpage>585</lpage><pub-id pub-id-type="pmid">16406232</pub-id></citation></ref><ref id="b68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sossa</surname><given-names>KG</given-names></name><name><surname>Beattie</surname><given-names>JB</given-names></name><name><surname>Carroll</surname><given-names>RC</given-names></name></person-group><article-title>AMPAR exocytosis through NO modulation of PICK1</article-title><source>Neuropharmacology</source><year>2007</year><volume>53</volume><fpage>92</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">17555774</pub-id></citation></ref><ref id="b69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Staudinger</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Burgess</surname><given-names>R</given-names></name><name><surname>Elledge</surname><given-names>SJ</given-names></name><name><surname>Olson</surname><given-names>EN</given-names></name></person-group><article-title>PICK1: a perinuclear binding protein and substrate for protein kinase C isolated by the yeast two-hybrid system</article-title><source>J. Cell Biol.</source><year>1995</year><volume>128</volume><fpage>263</fpage><lpage>271</lpage><pub-id pub-id-type="pmid">7844141</pub-id></citation></ref><ref id="b70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Staudinger</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Olson</surname><given-names>EN</given-names></name></person-group><article-title>Specific interaction of the PDZ domain protein PICK1 with the COOH terminus of protein kinase C-alpha</article-title><source>J. Biol. Chem.</source><year>1997</year><volume>272</volume><fpage>32019</fpage><lpage>32024</lpage><pub-id pub-id-type="pmid">9405395</pub-id></citation></ref><ref id="b71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Steigerwald</surname><given-names>F</given-names></name><name><surname>Schulz</surname><given-names>TW</given-names></name><name><surname>Schenker</surname><given-names>LT</given-names></name><name><surname>Kennedy</surname><given-names>MB</given-names></name><name><surname>Seeburg</surname><given-names>PH</given-names></name><name><surname>K&#x000f6;hr</surname><given-names>G</given-names></name></person-group><article-title>C-Terminal truncation of NR2A subunits impairs synaptic but not extrasynaptic localization of NMDA receptors</article-title><source>J. Neurosci.</source><year>2000</year><volume>20</volume><fpage>4573</fpage><lpage>4581</lpage><pub-id pub-id-type="pmid">10844027</pub-id></citation></ref><ref id="b72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stocca</surname><given-names>G</given-names></name><name><surname>Vicini</surname><given-names>S</given-names></name></person-group><article-title>Increased contribution of NR2A subunit to synaptic NMDA receptors in developing rat cortical neurons</article-title><source>J. Physiol.</source><year>1998</year><volume>507</volume><fpage>13</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">9490809</pub-id></citation></ref><ref id="b73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tokumitsu</surname><given-names>H</given-names></name><name><surname>Chijiwa</surname><given-names>T</given-names></name><name><surname>Hagiwara</surname><given-names>M</given-names></name><name><surname>Mizutani</surname><given-names>A</given-names></name><name><surname>Terasawa</surname><given-names>M</given-names></name><name><surname>Hidaka</surname><given-names>H</given-names></name></person-group><article-title>KN-62, 1-[<italic>N,O</italic>-bis(5-isoquinolinesulfonyl)-<italic>N</italic>-methyl-L-tyrosyl]-4-phenylpiperazine, a specific inhibitor of Ca<sup>2+</sup>/calmodulin-dependent protein kinase II</article-title><source>J. Biol. Chem.</source><year>1990</year><volume>265</volume><fpage>4315</fpage><lpage>4320</lpage><pub-id pub-id-type="pmid">2155222</pub-id></citation></ref><ref id="b74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tovar</surname><given-names>KR</given-names></name><name><surname>Westbrook</surname><given-names>GL</given-names></name></person-group><article-title>The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro</article-title><source>J. Neurosci.</source><year>1999</year><volume>19</volume><fpage>4180</fpage><lpage>4188</lpage><pub-id pub-id-type="pmid">10234045</pub-id></citation></ref><ref id="b75"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wayman</surname><given-names>GA</given-names></name><name><surname>Lee</surname><given-names>Y</given-names></name><name><surname>Tokumutsi</surname><given-names>H</given-names></name><name><surname>Silva</surname><given-names>A</given-names></name><name><surname>Soderling</surname><given-names>T</given-names></name></person-group><article-title>Calmodulin-kinases: modulators of neuronal development and plasticity</article-title><source>Neuron</source><year>2008</year><volume>59</volume><fpage>914</fpage><lpage>931</lpage><pub-id pub-id-type="pmid">18817731</pub-id></citation></ref><ref id="b76"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wenthold</surname><given-names>RJ</given-names></name><name><surname>Petralia</surname><given-names>RS</given-names></name><name><surname>Blahos</surname><given-names>J II</given-names></name><name><surname>Niedzielski</surname><given-names>AS</given-names></name></person-group><article-title>Evidence for multiple AMPA receptor complexes in hippocampal CA1/CA2 neurons</article-title><source>J. Neurosci.</source><year>1996</year><volume>16</volume><fpage>1982</fpage><lpage>1989</lpage><pub-id pub-id-type="pmid">8604042</pub-id></citation></ref><ref id="b77"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>Y</given-names></name><name><surname>Kelly</surname><given-names>MT</given-names></name><name><surname>Sajikumar</surname><given-names>S</given-names></name><name><surname>Serrano</surname><given-names>P</given-names></name><name><surname>Tian</surname><given-names>D</given-names></name><name><surname>Bergold</surname><given-names>PJ</given-names></name><name><surname>Frey</surname><given-names>JU</given-names></name><name><surname>Sacktor</surname><given-names>TC</given-names></name></person-group><article-title>PKM zeta maintains late long-term potentiation by N-ethylmaleimide-sensitive factor/GluR2-dependent trafficking of postsynaptic AMPA receptors</article-title><source>J. Neurosci.</source><year>2008</year><volume>28</volume><fpage>7820</fpage><lpage>7827</lpage><pub-id pub-id-type="pmid">18667614</pub-id></citation></ref><ref id="b78"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zamanillo</surname><given-names>D</given-names></name><name><surname>Sprengel</surname><given-names>R</given-names></name><name><surname>Hvalby</surname><given-names>O</given-names></name><name><surname>Jensen</surname><given-names>V</given-names></name><name><surname>Burnashev</surname><given-names>N</given-names></name><name><surname>Rozov</surname><given-names>A</given-names></name><name><surname>Kaiser</surname><given-names>KM</given-names></name><name><surname>K&#x000f6;ster</surname><given-names>HJ</given-names></name><name><surname>Borchardt</surname><given-names>T</given-names></name><name><surname>Worley</surname><given-names>P</given-names></name><name><surname>L&#x000fc;bke</surname><given-names>J</given-names></name><name><surname>Frotscher</surname><given-names>M</given-names></name><name><surname>Kelly</surname><given-names>PH</given-names></name><name><surname>Sommer</surname><given-names>B</given-names></name><name><surname>Andersen</surname><given-names>P</given-names></name><name><surname>Seeburg</surname><given-names>PH</given-names></name><name><surname>Sakmann</surname><given-names>B</given-names></name></person-group><article-title>Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning</article-title><source>Science</source><year>1999</year><volume>284</volume><fpage>1805</fpage><lpage>1811</lpage><pub-id pub-id-type="pmid">10364547</pub-id></citation></ref><ref id="b79"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zucker</surname><given-names>RS</given-names></name><name><surname>Regehr</surname><given-names>WG</given-names></name></person-group><article-title>Short-term synaptic plasticity</article-title><source>Annu. Rev. Physiol.</source><year>2002</year><volume>64</volume><fpage>355</fpage><lpage>405</lpage><pub-id pub-id-type="pmid">11826273</pub-id></citation></ref></ref-list></back></article> 